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1. Introduction 
Calcium phosphate nanoparticles have gained increasing interest in the last 
years due to their high biocompatibility which is due to the fact that calcium 
phosphate constitutes the inorganic mineral of mammalian bone and teeth.[1-
6] They are widely used in medicine for biomaterials (e.g., bone 
regeneration, tooth substitutes, etc.) and drug delivery vehicles.[2, 7, 8]  
Calcium phosphate nanoparticles can be used as fluorescing probes after 
doping with lanthanides.[9-13] Eu3+-doped fluorescing calcium phosphate 
nanoparticles with high internal crystallinity and with a shell of DNA were 
used to track the nanoparticles in cell transfection studies.[13] However, the 
fluorescence efficiency of lanthanide-doped calcium phosphates is limited 
by the necessity for a crystalline environment of the lanthanide in order to 
give a good fluorescence. This is difficult to achieve for calcium phosphate 
nanoparticles.[13] Biocompatible fluorescing nanoparticles have gained much 
interest in biomedicine.  
Calcium phosphate nanoparticles can act as drug-carriers, e.g. for nucleic 
acids[8] or for antitumor drugs.[14, 15] For instance, a successful cell 
transfection has been accomplished with DNA- and siRNA-coated calcium 
phosphate nanoparticles.[16-20] Nucleic acid-loaded calcium phosphate 
nanoparticles show an effective transfection where the calcium phosphate 
nanoparticles act as a carrier. Nucleic acids show a good interaction with a 
calcium phosphate surface and are able to stabilize calcium phosphate in the 
form of a colloid.[8, 18, 20-22] However, the nature of the interface between 
DNA and calcium phosphate remains largely unknown, although it can be 
assumed that there is a specific interaction between the phosphate groups of 
DNA and the calcium phosphate surface. To understand the interaction of 
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calcium phosphate with biological macromolecules like DNA, an organic 
phosphate-functionalized calcium phosphate surface was used as a model 
system in the present study. It is also of interest in biological and material 
sciences to clarify the interaction between calcium phosphate and organic 
phosphates, which is important in biological mineralization and 
calcification. Because a variety of phospholipids and phosphoproteins are 
present in calcifying tissues, body fluids and cell matrix vesicles which play 
a crucial role in the biological mineralization (inhibiting, nucleating or 
enhancing the crystal growth of calcium based biominerals).[23-26] The aim of 
my Ph.D work was to functionalize calcium phosphate nanoparticles with 
organic phosphates.  
Organic phosphates have high chemical affinity to bind with calcium 
phosphate surface. Taking this in to consideration, the functionalization of 
calcium phosphate nanoparticles is mainly done using organic phosphates. 
Organic phosphates used in the present study are represented here.  
Porphyrin     : 5,10,15,20-tetrakis(4-phosphonooxyphenyl)porphine  
Phytic acid     : myo-inositol-1,2,3,4,5,6-hexakisphosphate 
Phosphoamino acid : O-phospho-L-tyrosine 
Surfactants   : dodecyl phosphate, tetradecyl phosphate,  
    octadecyl phosphate, p-dodecyloxyphenyl phosphate  
    and p-dodecyloxybiphenyl phosphate  
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2. Theoretical background 
2.1. Biomineralization 
The controlled formation of inorganic minerals by living organisms in the 
form of skeleton, shells, teeth, etc. is called biomineralization. This yields 
amorphous and crystalline biogenic materials that often exhibit remarkable 
morphological and mechanical properties. The major metal ions deposited in 
unicellular and multicellular organisms are the alkaline earth divalent cations 
(Mg, Ca, Sr, Ba), the transitions metal, Fe, and the semi metal, Si. These 
usually form solid phases with the anions carbonate, oxalate, phosphate, 
sulfate and hydroxide/oxide. Less common are metals such as Mn, Au, Ag, 
Pt, Cu, Zn, Cd, and Pb which are deposited in bacteria, often as metal 
sulfides.[27]  
The biomineralization processes mainly takes place in a controlled reaction 
environment and furthermore the biomineral phases have properties such as 
shape, size, crystallinity, isotopic, and trace element compositions unlike its 
inorganically formed mineral phases. Figure 1 illustrates the comparison of a 
single calcite crystal formed by an echinoderm and a synthetic single 
crystals of calcite.[28] Echinoderms live in marine environment and form 
mineralized hard parts (skeleton, spines, spicules, ossicles and teeth) 
containing mostly magnesium-bearing calcite.[6]  These mineralized hard 
parts have the stereom structure (spongy or fenestrate) and a complex system 
of interconnecting cavities of mineralized calcite (Fig. 1a). The fracture 
surfaces of echinoderm calcite are smooth and glassy. Whereas the 
synthetically prepared single crystals of calcite have a rhombohedral shape 
(Fig. 1b). Much of the research work in biomineralization is focused at 
understanding the control processes that organisms have worked out.  
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Figure 1: Comparison of SEM pictures of calcite single crystals: (a) stereom 
space and the highly curved surfaces of echinoderm and (b) synthetically 
prepared rhombohedral forms. The figures were adapted from reference[28] 
 
Biomineralization processes are divided into two fundamentally different 
groups based upon their degree of biological control. The two groups are 
“biologically induced” and “biologically controlled” mineralization. 
Sometimes the undesirable metabolic end-products or ions are released by 
organisms through passive diffusion or active pumping or secretion. These 
byproducts combine with other ions in the external medium and induce 
mineral formation to precipitate. The type of mineral formed by this method 
is dependent on the environmental conditions in which the organism lives. 
The same organism in different environments can form different minerals. 
Mineral formation occurs as a result of interactions between biological 
activity and the aqueous environment in which organisms live is termed 
“biologically induced” mineralization. In “biologically controlled” 
mineralization, the organism uses cellular activities to direct the nucleation, 
growth and final location of the mineral that is deposited.[28] 
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2.2. Calcium-based biominerals 
Calcium is an alkaline earth metal belonging to Group II of the periodic 
table. It is a divalent cation with an atomic weight of 40 and shows a single 
oxidation state of +2. It is an essential element of all cells and organisms.  
 
Table 1: The names and chemical compositions of calcium-based minerals 
produced by biologically-induced and controlled mineralization process.[6] 
Mineral Formula 
 
Calcium carbonate:  
Calcite 
 
CaCO3  
Aragonite CaCO3  
Vaterite CaCO3  
Calcium carbonate monohydrate CaCO3·H2O 
Calcium carbonate hexahydrate CaCO3·6H2O 
Amorphous calcium carbonate CaCO3·nH2O 
Protodolomite CaMg(CO3)2 
 
Calcium phosphate:  
Hydroxyapatite 
 
Ca10(PO4)6(OH)2 
Fluroapatite (francolite) Ca10(PO4)6F2 
Carbonated hydroxyapatite (dahllite) Ca5(PO4,CO3)3(OH) 
Whitlockite Ca18H2(Mg,Fe(II))2(PO4)14 
Octacalcium phosphate Ca8H2(PO4)6·5H2O 
β-Tricalcium phosphate Ca3(PO4)2 
Brushite CaHPO4·2H2O 
Amorphous calcium phosphate Cax(PO4)y·nH2O 
 
Calcium oxalate:  
Whewellite 
 
CaC2O4·H2O 
Weddellite CaC2O4·2H2O 
 
Calcium sulfate: 
Gypsum 
 
CaSO4·2H2O 
Bassanite CaSO4·0.5H2O
 
Calcium fluoride: 
Fluorite 
 
CaF2 
 
Organic crystals: 
Earlandite 
 
Ca3(C6H5O2)2·4 H2O 
Calcium tartrate C4H4CaO6 
Calcium maleate C4H4CaO5
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About half of all biominerals consists of poorly water-soluble calcium-rich 
compounds because calcium fulfills many fundamental functions in the 
cellular metabolism.[6, 49-51] A wide range of calcium-based biominerals is 
shown in Table 1. 
 
2.2.1. Calcium carbonate 
The calcium carbonate minerals are the most abundant biogenic minerals, 
both in terms of the quantities produced and their widespread distribution 
among many different biological groups.[6] Calcium carbonate exists in a 
variety of polymorphic phases shown in table 1, of which calcite, aragonite 
and vaterite are the anhydrous crystalline polymorphs. They have typical 
morphologies: calcite – rhombohedral, aragonite – needles, and vaterite – 
polycrystalline spheres. Calcite and aragonite are the two most common 
polymorphs found in biological and geological samples and 
thermodynamically stable phases.[1, 29] They are the basic minerals used to 
build the shells. For example, the layered structure of the abalone shell is 
composed of alternating sheets of crystalline calcite and aragonite 
intertwined with organic binders.[30] The shell gains strength and limits crack 
propagation because it is an organic-inorganic composite composed of two 
polymorphs. The grinding teeth of the sea urchin are composed of calcite but 
hardened with small amounts of magnesium.[31] Calcite and aragonite are 
also used as gravity sensors in land and sea animals.[1] Magnesium ions are 
often incorporated and many biological calcites contain up to 30% of 
Mg2+.[29] Vaterite is a metastable polymorph with respect to calcite and 
aragonite and not commonly formed by organisms.[32-34] Calcium carbonate 
monohydrate and calcium carbonate hexahydrate (ikaite) are two hydrated 
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crystalline pseudopolymorphs. Calcium carbonate monohydrate is rarely 
found in biology.[29, 35] The hexahydrate phase is found naturally only in sea 
water.[29, 36] Amorphous calcium carbonate is intrinsically unstable 
thermodynamically and kinetically at physiological condition.[6] It is found 
in biology,[37] e.g. the cystoliths in leaves of certain plants,[38, 39] exoskeletons 
of crustaceans,[6] and ascidians.[40] 
 
2.2.2. Calcium phosphate 
Calcium phosphates are very important inorganic minerals of biological hard 
tissues. The most abundantly produced phosphate mineral is carbonated 
hydroxyapatite, also called dahllite, closely associated with bone and teeth.[6] 
Dentin and cementum in the tooth and the various forms of bone[41] contain 
approximately 70 wt% apatite with 20% collageneous matrix and 10% 
water. Unlike the other hard tissues, the internal structure of enamel which 
contains no cells or pores, consists of about 95 wt% hydroxyapatite 
mineral.[42] Enamel also differs in the way it is associated with the proteins 
enamelin and ameliogenin rather than collagen. While these biomaterials 
have broad similarities, they differ in important details including their minor 
elements, water composition, and the degree of crystallinity.[42] The 
biological apatite is known to be nanocrystalline and is formed biologically 
under mild conditions (ambient pressure, near room temperature).[2] Pure 
hydroxyapatite never occurs in biological systems.[2] However, because of 
the chemical similarities to bone and teeth mineral, hydroxyapatite is widely 
used as a coating for orthopedic (e.g. hip-joint prosthesis) and dental 
implants.[43, 44] Amorphous calcium phosphate is often encountered as a 
transient phase during the formation of calcium phosphates in aqueous 
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systems. Amorphous calcium phosphate and octacalcium phosphate are 
believed to be precursors to hydroxyapatite.[45-47] 
 
2.2.3. Calcium sulphate 
Calcium sulphate is a very important geological mineral. It is rarely found as 
a product of biomineralization[6, 48, 49], which may be due to the high 
solubility of calcium sulfates compared to carbonates, and phosphates. It is 
found in three stable geological polymorphs defined by the content of water 
incorporated into their crystal structure: CaSO4·2H2O (gypsum), 
CaSO4·0.5H2O (bassanite) and CaSO4 (anhydrite). Gypsum is a common 
mineral found either in discrete deposits or together with other minerals. 
Statoliths of gypsum were found in the class Scyphozoa (Aurelia aurita and 
Chrysaora hysoscella, Semaeostomeae)[50-52] and in the class Cubozoa 
(Carybdea rastoni, Carybdeida; Chiropsalmus, Chirodropida)[50, 53, 54]. 
Bassanite was recently identified as the inorganic mineral of the statoliths of 
the scyphozoan medusa Periphylla periphylla (Coronatae).[55-58] 
 
2.2.4. Calcium oxalate 
Calcium oxalate is considered to be the most commonly occurring 
biomineral in higher plants.[59-61] It occurs in two hydration states in plants, 
as the monohydrate (Whewellite) and as the dihydrate (Weddelite).[60, 62] 
Whewellite is thermodynamically most stable phase of calcium oxalate. 
Calcium oxalate is the principal biomineral component present in urinal 
stone together with calcium phosphate. In urinal stones, inorganic crystals 
are always mixed with organic matrices such as lipids, carbohydrates, and 
 15
proteinaceous materials, and studies have shown that, although these organic 
materials account for only about 2% of the total mass, they play a very 
important role in the stone-formation process.[63, 64] Some microorganisms, 
especially bacteria or nanobacteria, accumulate preferentially in the kidney 
and have been reported to act as biomineralization centers to induce kidney 
stones and play an important role in urolithiasis.[65-71] Instead of promoting 
the formation of stones, oxalate-eating bacteria such as Oxalobacter 
formigenes can degrade oxalate and prevent the occurrence of calcium 
oxalate urolithiasis.[72, 73] Calcium oxalate produced by both plants and 
fungi[74, 75] can be transformed into CaCO3 by bacteria.[76, 77] 
 
2.2.5. Calcium fluoride 
Calcium fluoride (fluorite) is often found as a mixture with other minerals. 
The statoliths of marine mysid crustaceans are composed of fluorite, and that 
this mineral is also a principal phase of the gizzard plates of some 
tectibranch gastropods.[78] A small percentage of fluorite was found with 
calcite (CaCO3) and brucite (Mg(OH)2) in the fusiform spicules of 
Doridacean opisthobranchs.[79] 
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2.3. Conditions for the precipitation of calcium phosphate 
crystallization 
Calcium phosphates are the mineral component of bones and teeth. It is 
interesting to understand the physical mechanisms that underline their 
growth, dissolution and phase stability. Control is often achieved at the 
cellular level by the manipulation of solution states and the use of crystal 
growth modulators such as peptides or other organic molecules.  
 
2.3.1. Nucleation 
Nucleation is a significant process in biomineralization in constructing 
complex structures. Nucleation can be described as representing an 
activation energy barrier to the spontaneous formation of a solid phase from 
a super saturated solution.[80] The formation of stable clusters of ions or 
molecules is required for nucleation as the energy needed to form a new 
interface (ΔGI) in the clusters is less than the energy released by the 
formation of bonds in the bulk solid phase (ΔGB). Because the surface 
molecules are less bound to their neighbors than are those in the bulk, their 
contribution to the free energy of the new phase is greater. Figure 2 shows 
the free energy barrier for nucleation (ΔGN) as a function of cluster size (r). 
The difference between the free energy per molecule of the bulk and that of 
the surface is referred to as the interfacial energy (ΔGI). The interfacial 
energy is always positive and dependent on the surface area. It acts to 
destabilize the nucleus. As a consequence, at very small nucleus size when 
many of the molecules reside at the surface, the nucleus is unstable. Adding 
even one more molecule increases the free energy of the system. As a result, 
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the nucleus will dissolve. But once the stable nucleus attained, the nucleus 
grows large enough as the drop in free energy associated with formation of 
the bulk phase becomes sufficiently high. The surface free energy is 
unimportant at this stage. Because the bulk energy (ΔGB) is negative and is a 
function of volume. Every addition of a molecule to the lattice lowers the 
free energy of the system.  
 
Figure 2: Free energy of nucleation (ΔGN) as a function of cluster size (r). 
ΔGN* is the activation energy for nucleation and r* is the critical cluster 
radius.  
 
The free energy of formation of a nucleus, ΔGN, is given by the difference 
between the interfacial and bulk energies:  
ΔGN = ΔGI - ΔGB 
The activation energy for nucleation (ΔGN*) is given by the following 
equations:  
ΔGN* = 16 π  (ΔGI)3 / 3 (ΔGB)2 
ΔGB = kB T log SR 
r* 
ΔG ΔGI 
ΔGN
ΔGN* 
ΔGB 
r 
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where kB is Boltzmann's constant, T is the temperature, and SR is the relative 
supersaturation of the medium. 
Supersaturation is a measure of to what extent a solution is out of 
equilibrium and represents the thermodynamic driving force for inorganic 
precipitation.[1] Supersaturation is highly regulated in biology through the 
process of boundary-organized biomineralization. The supersaturation, S, is 
a unitless number which is proportional to the difference in chemical 
potential (Δµ) between the supersaturated solution and a solution at 
equilibrium with the solid.  
S = Δµ / kB T 
The supersaturation determines the mode of crystal growth and the net flow 
of energy across a given surface. When the solution is undersaturated, the 
mineral will dissolve. When the solution is supersaturated, the mineral will 
grow. If the supersaturation is high enough, the activation energy for 
nucleation (ΔGN*) can be decreased. As a result the rate of nucleation can be 
increased.  
Recently, the nucleation mechanism of hydroxyapatite nanocrystallites by 
the control of chondroitin sulfate was examined from the viewpoints of 
kinetics and interfacial structure and properties.[81] Figure 3 shows a scheme 
of the nucleation and growth mechanism of hydroxyapatite from aqueous 
solutions with chondroitin sulfate. It was found that chondroitin sulfate can 
change the interfacial properties of hydroxyapatite by the surface adsorption 
through the sulfate functional groups. This increased the stiffness of the 
organic molecule and also created new binding sites for calcium ions at the 
substrates. These binding sites could highly decrease the activation barrier 
for the nucleation process and acted as a template for oriented 
hydroxyapatite nucleation. The negatively charged ChS surface caused a 
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higher surface supersaturation at the substrate as a result an oriented 
hydroxyapatite assembly was formed by the growth and the coalescence of 
crystallites on the surface-modified substrate. Without this template 
molecule, the hydroxyapatite crystallites obtained from the solution was not 
ordered and the crystallites were assembled in a random manner.  
 
 
Figure 3: Schematic drawing of the nucleation and growth mechanism of 
hydroxyapatite from aqueous solutions with chondroitin sulfate (ChS). A, 
strong interaction between ChS and Ca2+, which facilitates the nucleation of 
hydroxyapatite in solution by producing locally a high degree of 
supersaturation. B, adsorption of ChS on the surface of a parent crystal 
improving the interfacial correlation. C, nucleation and adsorption of growth 
units on a substrate of ChS. D, growth and coalescence of crystallites to 
form highly oriented hydroxyapatite crystallites on the surface. The figures 
were adapted from reference.[81] 
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So, the interfacial structure match between hydroxyapatite crystallites and 
substrates was improved by the ChS template during the nucleation process. 
Therefore, this may be the reason why composites such as hard tissues 
resulting from mineralization under such conditions will become compact, 
ordered, and tough. 
 
2.3.2. Thermodynamic and kinetic crystal growth 
The thermodynamic driving force for nucleation of calcium phosphate is the 
reduction of free energy of the system through the formation of a low energy 
phase, in this case a crystalline phase. The simplest strategy for controlled 
growth in biomineralization consists of maintaining a low level of 
supersaturation as shown in Figure 4. 
As shown in Figure, the activation energy for the formation of the most 
stable crystalline phase of a compound is rather high, although it is 
thermodynamically favoured. The fast growing faces have high surface 
energies and they will vanish in the final morphology and vice versa. 
Although this purely thermodynamic treatment cannot always predict the 
crystal morphology, as crystallization and the resulting morphology often 
also rely on kinetic effects as well as on defect structures, it is the basis for 
the explanation of additive-mediated crystal morphology changes in 
biomimetic mineralization.  
Kinetic crystallization control is based predominantly on the modification of 
the activation energy barriers of nucleation, growth, and phase 
transformation.[82] In such cases, crystallization often proceeds by a 
sequential process involving structural and compositional modifications of 
amorphous precursors and crystalline intermediates through a kinetically 
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effective pathway, rather than a one-step thermodynamic pathway.[82-84] The 
formation of amorphous and intermediate precursors is faster because the 
activation energy is much lower. These phases grow and recrystallize into 
the crystalline phase which is thermodynamically more stable under the 
conditions of the performed precipitation.  
 
 
 
Figure 4: Crystallization pathways under thermodynamic and kinetic 
control. Pathway A, direct growth from solution, i.e. a system follows a one-
step route to the final mineral phase; Pathway B, growth from structurally-
modified precursors, i.e. a system proceeds by sequential precipitation. ΔGN 
= free energy of nucleation; ΔGg = free energy of growth; ΔGT = free energy 
of phase transformation.  
 
 
Solution 
Amorphous 
B 
Kinetic 
A
ΔGN(A)+ΔGg(A)
ΔGT2
ΔGT3 
ΔGT1
ΔGN(B) 
+ΔGg(B)
Thermodynamic 
(M+(aq) + X-(aq)) 
ΔG 
Final mineral 
(crystalline) 
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2.3.3. pH 
The pH affects both the solution as well as the mineral surface. In the 
solution, a shift to lower pH will lower the saturation state by shifting the 
balance of phosphate species from PO43- over HPO42- to H2PO4-. At the 
mineral surface, the pH can shift the surface charge by changing the 
distribution of proton and hydroxyl groups hydrating the interface. 
 
H3PO4 + H2O H3O+ + H2PO4-          pKa1 = 2.161
H2PO4- + H2O H3O+ + HPO42-          pKa1 = 7.207
HPO42- + H2O H3O+ + PO43-             pKa1 = 12.325  
 
The different phases of calcium phosphate minerals can be obtained by the 
combination of phosphate and calcium ions under basic pH values. During 
the precipitation of calcium phosphates from a neutral solution, the pH value 
generally decreases because of the release of protons that were formerly 
bound to hydrogen phosphate or dihydrogen phosphate. For hydroxyapatite, 
the point of zero charge occurs at pH = 7.3.[2, 42, 108] 
 
5Ca2+ (aq) + 3HPO42- (aq) + 5H2O (l) Ca5(PO4)3OH (s) + 4H3O+ (aq)  
 
Generally when homogeneous precipitation occurs, i.e. spontaneous 
nucleation and growth, unstable amorphous solids precede the formation of 
crystalline hydroxyapatite. If the acidity of the solution is increased, other 
precursor phases such as dicalcium phosphate dihydrate may form in 
accordance with Oswald’s rule of stages[85] which predicts that the least 
stable phase having the highest solubility is formed preferentially during a 
sequential precipitation. 
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2.3.4. Solubility product 
Calcium phosphates are less soluble under basic conditions. In order of 
increasing stability, the five principal calcium phosphate phases are 
amorphous calcium phosphate (nonstoichiometric), dicalcium phosphate 
dihydrate (brushite) (-log Ksp [37 °C] = 6.63 mol L-1), tricalcium phosphate 
(whitlockite) (-log Ksp [37 °C] = 29.55 mol L-1), octacalcium phosphate (-log 
Ksp [37 °C] = 97.4 mol L-1), and hydroxyapatite (Ca10(PO4)6(OH)2) (-log Ksp 
[37 °C] = 117.3 mol L-1).[2, 86] The final ratio present in each of these phases 
can affect the bulk and interfacial chemistry of the final calcium phosphate 
material. 
 
2.3.5. Temperature 
Temperature is generally an important crystal growth parameter, although it 
is not a variable in a regulated environment such as the body. Solubility 
products and association constants are affected mainly by a change in 
temperature because they are temperature-dependent. Temperature also 
affects the kinetics of adsorption, desorption, and diffusion.   
 
2.3.6. Presence of ions or additives 
The surface energy of a crystal face can be lowered by the adsorption of an 
additive. Therefore, the shape of crystals can be affected by various factors, 
i.e. inorganic ions or organic additives. The anisotropic growth of the 
particles can be explained by the specific adsorption of ions or organic 
additives to particular faces, therefore inhibiting the growth of these faces by 
lowering their surface energy. Only the additives that can adsorb on special 
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crystal faces can change the surface energies of the different crystal faces 
and change the crystallization process and the final morphology. For 
example, the substitution of the hydroxide ions in hydroxyapatite by fluoride 
ions results in greater structural stability. It is interesting to note that the 
incorporation of F- stabilizes the lattice and reduces its solubility. Shark 
enamel has a 1000 times higher fluoride concentration than the human 
enamel.[87] The small concentration of fluoride is beneficial in protecting the 
enamel of our teeth. The etching of enamel in our teeth by acidic food or 
beverages resulting in the dissolution of calcium hydroxyapatite can be 
lowered by replacing some hydroxide ions by fluoride ions. The salts of 
phytic acid inhibits effectively the crystallization of brushite in urine[88]. 
Kakizawa et al. prepared nanoparticles consisting of calcium phosphate, 
DNA and block-copolymers. A small size of the particles and good colloidal 
stability were achieved by the steric effect of a poly(ethylene glycol) (PEG) 
layer surrounding the calcium phosphate core.[89, 90] 
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2.4. Hollow inorganic nanoparticles 
Hollow inorganic micro- or nanostructures have attracted considerable 
attention because of their promising applications such as nanoscale chemical 
reactors, catalysts, drug-delivery carriers, lightweight fillers, low-dielectric 
materials or photonic crystals. Hollow structures of inorganic materials have 
been fabricated by template-assisted synthesis or template-free synthesis.  
 
2.4.1. Principles and methods of the synthesis of hollow inorganic 
particles 
Template-assisted synthesis is the mostly approached method to produce 
hollow inorganic structures. The general approach is the use of various 
removable or sacrificial templates, including hard (inorganic 
nanoparticles,[91] monodispersed silica[92, 93] or polymer latex spheres,[94-99] 
glass microspheres,[100, 101] and reduced metal nanoparticles[102, 103]) and soft 
templates (emulsion droplets[104, 105]/micelles[106-113] and gas bubbles 
generated from a reaction mixture[114]).  
A common template-assisted method to prepare nanostructures with a 
hollow interior is that the surfaces of templates are coated with thin layers of 
the desired material or its precursor, followed by the selective removal of the 
templates which involves the use of organic solvents (oil droplets and 
polystyrene spheres), strong acids (metal and inorganic nanoparticles) or 
calcination (micelles). 
For example, Peng et al.[114] used N2 microbubbles as templates to produce 
hollow microspheres of ZnSe (Fig. 5). In this study, the N2 gas bubbles were 
generated in situ during the reduction of SeO32- by hydrazine. Although the 
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template method satisfies the structural requirements to prepare hollow 
nanostructures, the removal of template turns out to be a difficult process in 
some cases. 
 
Figure 5: Schematic representation of the aggregation of ZnSe nanocrystals 
over N2 gas bubbles. Step (a): Reduction of SeO32- by hydrazine to form Se 
atoms and N2 microbubbles. The Se atoms were further reduced with 
alkaline solution to produce Se2- ions which reacted with ZnO22- or Zn2+ ions 
to form ZnSe nanocrystals. Step (b): Aggregation of ZnSe nanocrystals 
around gas-liquid interface between N2 gas bubbles and water. Step (c): 
Finally the formation of hollow microspheres of ZnSe. The figure was 
adapted from reference.[114] 
 
Template-free methods, involving self-assembly of nanoparticles,[115] 
oriented attachment of nanoparticles,[116, 117] Ostwald ripening[118, 119] and the 
Kirkendall effect[120-122] have been proposed recently to prepare hollow 
nanostructures of inorganic materials. These are the mostly preferred 
methods because of their easy way of one-pot synthesis and for the 
controlled preparation of hollow nanostructures in a wide range of sizes.  
Self-assembly of nanoparticles can produce higher-order architectures in situ 
by mesoscale transformation processes that involve metastable inorganic-
based colloidal aggregates.[82, 115] The self-assembly process is mainly driven 
by the interactions of organic ligands which are adsorbed on the inorganic 
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minerals.[123, 124] Recently, self-assembly of polymer-stabilized TiO2 and 
SnO2 solid nanoparticles with sizes of a few nanometer into hollow 
microspheres at relatively low temperatures has been reported.[115] 
Oriented attachment is known as a combination of nanocrystallites through 
their suitable surface planes, i.e., with the same crystallographic 
orientation.[125] This process refers to the crystal growth via direct 
attachment of the existing crystal planes or facets. An immediate result of 
this process is the dimensional multiplication of original basic units which 
can effectively produce the larger structures. By this method, a larger 
interior space can not be generated although intercrystallite porosity can be 
attained depending on the structural shapes of the primary building units. 
The oriented attachment of nanocrystallites is mainly driven by the internal 
core of the primary nanoparticles. Contrary to self-assembly of 
nanoparticles, oriented attachment is only observed for ligand-free 
nanoparticles.[124] The formation of hollow “Dandelions” structures by the 
mesoscale organization of CuO nanoribbons was reported[116] (Fig. 6).  
 
Figure 6: Schematic illustration of a two-step process of the dandelion 
organization of CuO: (a) oriented aggregation of CuO nanoribbons to form 
rhombic shaped nanostructure, and (b) geometric shape limiting assembly of 
the rhombic shaped nanostructures into a shell structure. The figures were 
adapted from reference[116] 
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Ostwald ripening commonly refers to the solution process in which large 
crystals grow at the expense of small ones. It is a suitable technique to 
prepare both crystalline and amorphous particles. Here the principle is to 
produce the initial spherical particles for which the external surface layer is 
less soluble compared to the interior core of the particles. It means that the 
external surface layer should have higher crystallinity and should be 
energetically more stable compared to the interior core particles. In order to 
minimize the surface energy of core particles during the ripening process, 
large crystallites on the external layer are essentially immobile while the 
smaller interior core particles tend to diffuse through solution and 
recrystallizing. This process creates the interior hollow space within the 
original aggregates. Based on this technique, numerous hollow inorganic 
particles have been synthesized.  
 
Figure 7: The proposed formation mechanism of calcite hollow spheres. (a) 
The polymer-stabilized amorphous nanoparticles. (b) Formation of spherical 
vaterite precursors. (c) Aggregation of the vaterite nanoparticles. (d) 
Vaterite–calcite transformation starting on the outer sphere of the particles. 
(e) Formation of calcite hollow spheres under consumption of the vaterite 
precursor. (f) SEM image of hollow CaCO3 particle. The figures were 
adapted from reference.[32] 
 
For instance, Yu et al. reported the synthesis of hollow CaCO3 
microparticles in the presence of double-hydrophilic block copolymers[32] 
(Fig. 7). The crystallization of a calcite rhombohedral structure occurred on 
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the initially formed vaterite (thermodynamically less stable) particles. These 
rhombohedral crystals then grew at the expense of the dissolving vaterite 
particles by Ostwald ripening, resulting in a hollow sphere. The inner part of 
the hollow particle consisted of tiny primary nanocrystals with a grain size 
of about 320 nm as indicated by the arrow. 
The Kirkendall effect was found by E. O. Kirkendall[121] as a diffusion 
phenomenon in metallurgy and normally refers to comparative diffusive 
migrations among different atomic species in metals and alloys under 
heating conditions. For example zinc diffuses into copper faster than copper 
diffuses into brass in a brass-copper interface due to their different atomic 
diffusivities.[125] As a result from this diffusion process, porosity will be 
generated in the lower-melting component side of the diffusion couple. 
Based on this technique, hollow nanoparticles are formed by crystalline 
materials, such as ZnO, CuS, and Co3S4.[126-128] 
 
 
Figure 8: Schematic illustration of formation of cobalt sulfide (Co3S4, 
linaeite) hollow spheres by the Kirkendall effect. The figure shows the 
temperature dependence of hollow particle evolution at low (LT) and high 
(HT) temperatures. The figures were adapted from reference[128] 
 
Yin et al.[128] synthesized linaeite (Co3S4) hollow particles by reacting 
colloidal cobalt nanoparticles with molecular sulfur in solution (Fig. 8). The 
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void formation process was dominated by outward diffusion of cobalt 
cations. At room temperature, hollow cobalt sulfide nanoparticles were 
observed only after 19 hours but the voids were in irregular shape. The 
reaction rate increased dramatically with increase of temperature. At 120°C, 
the well-centered circular voids were observed within 20 minutes. 
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2.5. Colloids 
The term colloid (which means “glue” in Greek) was first introduced in 
1861 by Thomas Graham to describe the “pseudosolutions” in aqueous 
systems of silver chloride, sulfur, and Prussian Blue which were prepared by 
Francesco Selmi in the mid-nineteenth century.[129] Graham deduced that the 
colloidal size range is approximately 1 μm down to 1 nm (i.e. 10-6 – 10-9 m). 
The colloids are generally described as systems consisting of one substance 
finely dispersed in another. These substances are referred to as the dispersed 
phase and dispersion medium (or continuous phase) respectively. The 
colloid system can be a solid, a liquid, or a gas.  
 
2.5.1. Functionalization of calcium phosphate nanoparticles 
Calcium phosphate particles in the nanometer scale tend to aggregate 
immediately due to van der Waal's forces. The nanoparticles must be 
stabilized as colloids where the repulsive forces between the nanoparticles 
must be provided to balance this attraction. Generally two types of 
stabilization are used to prevent agglomeration of nanoparticles, namely, 
electrostatic stabilization and steric stabilization by adsorbed molecules or 
steric hindrance. Electrostatic stabilization involves the creation of an 
electrical double layer arising from ions adsorbed on the surface and 
associated counter ions that surround the particle. Thus, if the electric 
potential associated with the double layer is sufficiently high, the Coulomb 
repulsion between the particles will prevent their agglomeration (Fig. 9). 
The functionalization can stabilize the particles against fusion or 
agglomeration and thus assure a homogeneous distribution within the 
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colloidal solution. Steric stabilization can be achieved by the adsorption of 
large molecules such as polymers at the surface of the particles. The calcium 
phosphate nanoparticles functionalized with DNA provide both electrostatic 
and steric stabilization.  
 
 
Figure 9: Schematic diagram illustrates the solid particles in colloidal 
solution. The unfunctionalized nanoparticles tend to collide and aggregate 
(left side) and functionalized nanoparticles repel each other (right side).  
 
Surface functionalization of calcium phosphate nanoparticles can modify the 
physical properties of the nanoparticles (e.g. surface charge density, 
solubility, dispersive nature, etc). Figure 10 shows the model for the 
stabilization of positively charged nanoparticle by charging the surface with 
counter ions. The specific adsorption of additives or ions on the particles 
surface, even at low concentrations, can have a dramatic change in zeta 
potential. The zeta potential is the difference in electrical potential between 
the dense layer of ions surrounding the particle and the bulk of the 
suspended fluid. For example, the charge of the calcium phosphate 
nanoparticles is slightly positive above pH 7. After functionalizing the 
surface of calcium phosphate nanoparticles with nucleic acids, the zeta 
potential value was reduced to negative (-20 to -30 mV), i.e. the surface was 
charged negatively because of the non-covalent adsorption of negatively 
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charged nucleic acids on the positively charged calcium phosphate 
surface.[22]  
 
 
Figure 10: Schematic representation of the stabilization of a positively 
charged nanoparticle by charging the surface with counter ions. 
 
Lebugle et al. functionalized the hydroxyapatite surface with 
(hydroxyethyl)methacrylate phosphate and dodecanol phosphate by a 
coprecipitation method in order to disperse the hydroxyapatite particles in 
polymers as a filler cement used in dental and medical therapies[130-132]. 
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2.6. Organic phosphates as functionalizing agents 
Biological molecules possessing phosphate functional groups form a large 
part of the cellular matrix. Their importance is underlined by their presence 
in nucleic acids, proteins, carbohydrates, lipids, coenzymes, and steroids.  
 
2.6.1. Porphyrin 
Porphyrins are ubiquitous class of naturally occurring compounds with many 
important biological examples including hemes, chlorophylls, myoglobins, 
cytochromes, uroporphyrin, coproporphyrin, catalases, peroxidases, etc. 
They are utilized by the nature in importance of many biological processes, 
for instance oxygen storage and transport (myoglobin and hemoglobin), 
electron transport (cytochromes b and c), oxygen activation and utilization 
(cytochrome P450 and cytochrome oxidase), photosynthesis in plants and 
bacteria (chlorophyll and pheophytins) and several others.  
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Figure 11: Chemical structure of the porphyrin skeleton. 
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The parent macrocyclic structure shown in Figure 11 is called porphyrin, a 
name originally used (in hematoporphyrin) by Hoppe-Seyler in 1877[133]. 
The porphyrin contains a fundamental skeleton of four pyrrole nuclei united 
through the α-positions by four methine groups to form a conjugated 
macrocyclic structure (porphyrin is designated porphine in  the Chemical 
Abstracts index). The numbering of ring positions including nitrogen is also 
shown in Figure 11. The Greek letters are sometimes used to distinguish the 
types of carbon positions. This macrocyclic structure has 22 π electrons; 
among them only 18 π electrons are involved in aromaticity according to 
Hueckel’s rule.  
Porphyrin compounds are known as analytical reagents with highly sensitive 
spectrometric and/or spectrofluorimetric properties. A very intense 
absorption band is known as the Soret band [134], named after the biochemist 
who first observed it in hemoglobin. The Soret band normally occurs around 
400 nm in the near ultraviolet (ε > 105 dm3 cm-1 mol-1) followed by four 
weaker absorptions (Q bands) at higher wavelengths from 450 to 700 nm. 
The protonation of the inner nitrogen ring or insertion/change of metal atoms 
into the macrocycle strongly affects the electronic conditions and causes 
major changes in the absorption spectra of porphyrin. A disrupted porphyrin 
macrocycle results in the disappearance of the Soret band [135]. Upon the 
formation of a metalloporphyrin complex, the absorption spectrum of the 
soret band shows a slight red shift, whereas the four weaker Q bands merge 
into two bands at the higher wavelength between 500 to 650 nm [136]. 
The porphyrin macrocycle and its derivatives are amphoteric, behaving both 
as acid and as base. The nitrogen atoms at the centre of the porphyrin core 
are responsible for this interesting property. The N-H groups can be 
deprotonated with strong bases, while the two-imine nitrogens can be 
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protonated with acids. However, metalloporphyrin lacks this amphoteric 
quality because the nitrogen atoms are chelated to the metal with both 
covalent and dative bonds. The NMR spectrum of the aromatic tetrapyrrole 
shows anisotropic effects.[137-140] The ring current generated by the applied 
field induces a local magnetic field similar to that in benzene. The N-H 
protons inside the porphyrin ring system are therefore shifted upfield to as 
high as -5 ppm in porphyrins whereas the deshielded meso-protons appear at 
very low field (δ ≈ 10 ppm).[141] The pyrrolic protons are also deshielded and 
tend to resonate at δ = 8 to 9, versus δ ≈ 6 ppm in pyrrole. Although the 
aromaticity of these porphyrin systems makes their NMR spectra a challenge 
to assign, the tendency towards aggregation in some cases causes even more 
complicated spectra[142]. Another fundamental aspect of the chemistry of 
porphyrins is the tautomerism of the “inner” hydrogen. The tautomerism of 
N-H was shown by low-temperature 1H- and 13C-NMR spectroscopy.[143-145] 
Porphyrins are well known fluorescing molecules. They are extensively used 
as photosensitizers in photodynamic therapy for the treatment of cancer. 
Photodynamic therapy, the name arises from the term photodynamische 
wirkung (photodynamic effect) coined by German physiologists to describe 
the damage of a living tissue by a combination of photosensitizer, visible 
light and oxygen.[146, 147] Bonnett described schematically the important steps 
involved in medical treatment of cancer cells using photodynamic 
therapy,[146] which is shown in Figure 12. The porphyrins can be 
administered both in dissolved form as well as adsorbed on 
nanoparticles.[148-152] The distribution of porphyrin in the body is still under 
examination. Since the porphyrins are solids, a liquid medium is needed for 
injection purposes. It is known that 70 % of the human body weight is 
composed of water. The porphyrin skeleton (see Fig. 11) is adequately 
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hydrophobic. Sufficient solubility of the sensitizer in aqueous media is 
important for direct intravenous application and transport to the intended 
target location. Hydrophobic, insoluble sensitizers can be transported by 
water-soluble carriers [153-155]. The possible cariers are micellar suspensions 
or liposomes, biopolymers (nucleic acids), serum proteins (albumin, high-
density lipoproteins and low-density lipoproteins), antibodies (natural 
carriers), and container molecules (cyclodextrins, calix[n]arenes) [156]. 
 
Figure 12: Schematic diagram of photodynamic therapy using a 
photosensitizing agent. Figure was adapted from reference.[146] 
 
After administration of porphyrin in tumor tissue, visible light of a specific 
wavelength is used to irradiate the tumor which causes excitation of 
porphyrin. This energized porphyrin will react with molecular oxygen and 
other substrates generating highly reactive cytotoxic species e.g. singlet 
oxygen, peroxides, superoxide anion, hydroxyl redical which will destroy 
the tumor cell preferentially. 
Hematoporphyrin, is named by Hoppe-Seyler [157], was the first porphyrin 
administered in PDT, which is available from blood. In 1841 Sherer isolated 
hematoporphyrin from blood, during experiments investigating the nature of 
blood [158].  In 1913 Meyer-Betz injected himself with 200 milligrams of 
hematoporphyrin, in order to determine its photosensitivity in human. He 
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registered no ill effects until he exposed himself to sunlight, whereupon he 
suffered extreme swelling, this photosensitivity remained for several months 
[159]. Lipson et al described that hematoporphyrin derivative is a diagnostic 
tool for PDT [160].  
 
2.6.2. Phytic acid 
Phytic acid, myo-inositol-1,2,3,4,5,6-hexakisphosphate is present in large 
amounts in plants, seeds and grains. It is called phytate when it exists in the 
salt form. It is commonly found in nature and exists in plants in the form of 
its mixed calcium and magnesium salts (called phytin). About 60~90% of 
the entire amount of phosphorus occurring as organic phosphate in plants are 
in the form of phytin.  
Phytic acid is also found in animal blood. It has a beneficial role as 
hemoglobin cofactor[161] in the regulation of oxygen transport in human 
blood.[162-164] The presence of phytate in normal urine[165] exerts a potent 
action as crystallization inhibitor of oxalate and phosphate salts of calcium 
in urine.[166-168] The primary enzymes responsible for the degradation of 
phytic acid are phytases. Phytases are a special class of phosphatases that 
catalyze the sequential hydrolysis of phytic acid to inositol phosphates and, 
in some cases, to inositol. 
The conformation of phytic acid has been a topic of much interest. In the 
solid state, the hydrated dodecasodium salt of phytic acid adopts the 
conformation that contains five phosphates in axial (ax) positions and one 
phosphate in equatorial (eq) position (5ax/1eq)[169, 170] (Fig. 13). The driving 
force for adopting the sterically hindered 5ax/1eq form is the minimization 
of electrostatic repulsion between the five contiguous dianionic phosphates 
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in the equatorial positions and stabilization of the axial phosphates by 
coordination with sodium ions and hydrogen-boding interactions with 
water.[170] In aqueous solution, the 1ax/5eq form exists below pH 9.5. Above 
this pH, the stable conformation is the 5ax/1eq form.[170-173] 
 
 
 
Figure 13: 5ax/1eq and 1ax/5eq conformations of phytic acid. P = -OPO3H2, 
-OPO3H- or -OPO32-, depending on the pH. The numbering corresponds to 
cyclohexyl carbons carrying the phosphate groups. Each phosphorus atom is 
labeled with the same number as the carbon to which it is linked.  
 
Phytic acid has the ability to bind minerals[174-176] and results in lower 
absorption of these elements in the body. However, recent work has shown 
that phytic acid has many health benefits. Phytic acid and its derivatives play 
an important role in RNA export, DNA repair, and DNA recombination in 
endocytosis and vesicular trafficking.[177] Phytic acid acts as an anticancer 
agent, and its action can be explained by its mineral-chelating potential.[178] 
Like other organic phosphates, it has a cariostatic effect that was ascribed to 
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its ability to inhibit the dissolution of tooth enamel by strong adsorption of 
phytate to the calcium phosphate surface of enamel.[179] Thereby, it is able to 
prevent the formation of cavities.[180-183] 
 
2.6.4. Amino acids with phosphate functional groups 
The term “protein” is derived from the Greek word proteuein which means 
“to be first”. Naturally occuring proteins consist of polymers of twenty two 
different amino acids.  
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Figure 14: The generalized structure of α-amino acids (top left) and the 
peptide bond, a linkage between two amino acids (top right). The chemical 
structures of phosphoserine, phosphothreonine and phosphotyrosine are 
illustrated in the bottom line (from left to right). 
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Amino acids consist of an alpha carbon atom (Cα) which is bound to an 
amino group (-NH2), a carboxyl group (-COOH), a hydrogen atom (-H) and 
a side chain R (Fig. 14). Amino acids are distinguished from one another by 
differences in their side chains. When amino acids are combined, an amide 
linkage called a peptide bond is formed and a molecule of water is released. 
Two amino acids form a dipeptide, three amino acids form a tripeptide, and 
many amino acids form a polypeptide. 
Phosphoserine, Phosphothreonine and phosphotyrosine are examples for 
phosphoamino acids (Fig. 14). In living cells, protein-phosphorylation 
occurs on serine, threonine and tyrosine residues. Generally, enzymes called 
kinases are involved in the process of phosphorylation and phosphatases are 
responsible for the dephosphorylation of proteins. The reversible 
phosphorylation of proteins is an important regulatory mechanism which 
occurs in both prokaryotic and eukaryotic organisms.[184-187] 
Tyrosine-phosphorylation is of great significance in cancer research because 
it inhibits the growth of human renal and breast carcinoma cells in vitro[188], 
although phosphotyrosine is less abundant than phosphoserine and 
phosphothreonine.[189] The enzymes called protein tyrosine kinases are 
involved in the phosphorylation of tyrosine and the activation of this enzyme 
results in an increase in overall cellular phosphotyrosine levels and induction 
of cell proliferation. The protein tyrosine phosphatases are enzymes that are 
found at cytosolic as well as at transmembrane sites. They are involved in 
the dephosphorylation of phosphotyrosyl residues of cellular proteins.[190, 191] 
O-phospho-L-tyrosine can activate cellular protein tyrosine phosphatases 
which inhibits the cell cycle by dephosphorylating the cellular 
phosphotyrosine and decreasing the activity of EGFR (epidermal growth 
factor receptor) kinase.[188, 190, 192] Mishra et al. reported that the incubation of 
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cells with O-phospho-L-tyrosine can lead to an arrest of cell growth, but this 
does not work with phosphothreonine or phosphoserine.[190] 
Phosphoproteins are proteins containing phosphate (PO4) groups. The 
addition of a phosphate molecule to a polar -R group of an amino acid 
residue can turn a hydrophobic portion of a protein into an extremely 
hydrophilic portion of molecule. Casein, vitellin, osteopontin, statherin, 
phosphophoryn are the best known phosphoproteins and they comprise the 
clusters of phosphoseryl residues. 
Phosphoproteins play a key role in promoting or inhibiting the growth of 
minerals like hydroxyapatite. The proline-rich acidic proteins such as 
statherin found in human salivary fluids function as an inhibitor of primary 
and secondary crystallization of the biomineral hydroxyapatite.[193-196] 
Recently, it has been predicted from NMR studies that phosphoserines of 
statherin protein play a vital role in binding affinity with hydroxyapatite 
through strong electrostatic interaction.[205, 207, 209] Makrodimitris et al. 
proposed a model for the interaction of statherin with the hydroxyapatite 
surface[197] (Fig. 15).  
Casein phosphopeptides bind to forming nanoclusters of amorphous calcium 
phosphate in metastable solution through their multiple phosphoseryl 
residues, thereby preventing their growth to the critical size required for 
nucleation and phase transformation.  Conformational and binding studies 
have shown that all the phosphoseryl residues are important in interaction 
with amorphous calcium phosphate. The composite of casein 
phosphopeptide-amorphous calcium phosphate can be added to sugar-
containing foods as well as oral care products for the control of dental 
caries.[198] 
 
 43
 
(a)  (b)  
 
Figure 15: The model structure of statherin and its adsorption onto the 
hydroxyapatite surface. (a) Statherin structure adapted from reference[197]. 
Sticks depict the two phosphoserine (Sep) side chains Sep2 and Sep3. (b) 
The interaction of statherin with the hydroxyapatite surface through anionic 
phosphate groups of phosphoserine. Sep3 chelates a Ca2+ ion (green) and 
Sep2 forms hydrogen bonds.  
 
Osteopontin is an acidic phosphoglycoprotein that is active in the prevention 
of soft tissue calcification. In vitro studies have shown that osteopontin can 
inhibit the formation of hydroxyapatite and other biologically relevant 
crystalline phases, and that this inhibitory activity requires the 
phosphorylation of the protein.[199] Osteopontin can be phosphorylated by 
casein kinase II, cAMP-dependent protein kinase, Golgi casein kinase and 
protein kinase C.[200-202] Threonine and serine are the amino acids that are 
phosphorylated in osteopontin.[203] 
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Phosphophoryn which is found in the dentin matrix is highly 
phosphorylated, and the phosphate groups are important for its function as a 
mediator of dentin mineralization.[204, 205] 
 
2.6.1. Surfactants 
Surfactants or surface-active agents are amphiphilic organic molecules 
which upon dissolution in a solvent at low concentration have the ability to 
adsorb at interfaces, thereby altering significantly the physical properties of 
those interfaces. Amphiphiles are described with regard to their 
“hydrophilic” and “hydrophobic” moieties, or “head” and “tail” respectively. 
Surfactants are soft templates and they have been found to play key roles in 
bio-inspired synthesis for mimicking the biomineralization process. 
Surfactants can form a wide variety of aggregate morphologies (Fig. 16). 
The morphology of the aggregate is determined by the molecular structure of 
the individual surfactant molecule and is the result of the interplay between 
the attractive hydrophobic interactions between the tails and the repulsive 
electrostatic and hydration shell overlap interactions between the head 
groups.[206]  
A micelle is a highly dynamic aggregate of surfactant molecules. The 
average residence time of a surfactant molecule in a micelle is around 10–5 to 
10–6 seconds, the lifetime of a micelle is 10–2 to 10–3 seconds.[207] The shape 
and size of the micelle is also subjected to variations.[208] A typical micelle 
consists of 40 to 100 amphiphile molecules[209]. The diameter of a micelle is 
about 5 nm. In 1925, a bilayered structure was proposed for cell 
membranes.[210] Later it was found that phospholipids extracted from cell 
membranes can form closed bilayer aggregates.[211] These structures are 
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called liposomes and have been frequently used as membrane models.[212] 
Vesicles consist of an aqueous compartment enclosed by a bilayer composed 
of amphiphiles. The hydrophobic part of the amphiphiles forms the inner 
core of the bilayer, whereas the hydrophilic head groups are located at the 
bilayer–water interface.  
 
 
 
Figure 16: Representation of micelles, vesicles and bilayers. 
 
Disodium monoalkyl phosphates are found to form both vesicles and 
micelles, depending of the pH conditions of the aqueous solutions.[213-216] 
Vesicles are normally formed at low pH[214], whereas micelles are formed at 
high pH.[215]  
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3. Results and discussion 
3.1. Synthesis and characterization of p-TPPP-functionalized 
calcium phosphate nanoparticles 
Calcium phosphate nanoparticles can be used as gene/drug carrier for 
nucleic acids[8] or for antitumour drugs.[14, 15] Recently, Han et. al. showed 
the influence of nanoapatite on cancer cells.[217] The experimental results 
indicated that the apatite nanoparticles got into the cancer cells, inhibited the 
growth of cancer cells and showed appearance of cell death. He also 
proposed the possible mechanism that the uptake of apatite nanoparticles 
result in the DNA damage on tumour cells and increase the cytosolic Ca2+ 
concentration which lead to apoptosis of tumor cells. Therfore, calcium 
phosphate nanoparticles can be used as antitumour drug and also possibly as 
antitumour drug carriers.  
Porphyrin and metal porphyrin complexes are well known fluorescing 
molecules with high stability and high fluorescence efficiency. They are also 
extensively used as dyes in photodynamic therapy for the treatment of 
cancer after uptake in tissue and irradiation with light, both in dissolved 
form as well as adsorbed on nanoparticles.[148-152]  
In the current study, calcium phosphate nanoparticles stabilized with a 
water-soluble porphyrin having four phosphate functional groups, namely 
5,10,15,20-tetrakis(4-phosphonooxyphenyl)porphine (p-TPPP), to improve 
the interaction with the calcium phosphate surface. Porphyrin-functionalized 
calcium phosphate nanoparticles may be used as biocompatible fluorescing 
nanoparticles. 
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3.1.1. Synthesis of 5,10,15,20-tetrakis(4-phosphonooxyphenyl)porphine 
(p-TPPP) 
5,10,15,20-tetrakis(4-phosphonooxyphenyl)porphine (p-TPPP) belongs to a 
class of meso-substituted synthetic porphyrins. It can be directly synthesized 
from 5,10,15,20-tetrakis(4-hydroxyphenyl)porphine (p-THPP) by 
phosphorylation of the hydroxyl groups. Kawakami et al.[218] prepared this 
compound using a mixture of pyrophosphate and phosphorus pentoxide as 
phosphorylating agents. By this method of preparation, it was difficult to 
purify the final product and the yield was also very poor. A two step 
procedure was followed to prepare p-TPPP from p-THPP. In the first step, p-
THPP was phosphorylated. Di-tert-butyl-N,N-diethyl-phosphoramidite was 
used as phosphitylating agents. MCPBA (meta-chloro perbenzoic acid) was 
used as oxidizing agent. The deprotection was achieved in the second step 
by acid treatment (HCl/1,4-dioxane) of the first step product. The 
phosphorylation (step a) and the deprotection (step b) are shown in Figure 
17. The procedure is easy and the product is obtained in high yield. Di-tert-
butyl-N,N-diethylphosphoramidite was prepared in high yield and also with 
high purity (90-95%), according to reference.[219] This reagent is a highly 
reactive phosphitylating agent, which after activation with 1H-tetrazole 
reacts rapidly with an aryl alcohol. The nitrogen group of phosphoramidite 
can be protonated by 1H-tetrazole, thus converting the amine into a good 
leaving group.[220] The phosphorus atom is then attacked by alcohol. At this 
point the phosphorus atom is in the +III oxidation state. After treating the 
alcohols with phosphoramidites, an oxidizing step is necessary to convert the 
phosphorus from the +III oxidation state to the +V oxidation state. The 
subsequent oxidation of the resultant alkyl or aryl phosphate triesters with 
MCPBA proceeds rapidly and gives phosphate triesters. 
 48
N
NH N
HN
N HN
NNH
O
P O
O O
O
P
OO
O
O
PO
O O
O P
O
O
O
HO
OH
OH
OH
(i)
(ii)
N HN
NNH
O
P O
NaO ONa
O
P
ONaNaO
O
O
PO
NaO ONa
O P
ONa
ONa
O
(iv)(iii)
Step a
Step b
p-THPP
 
 
Figure 17: Schematic diagram illustrating the synthesis of the sodium salt of 
p-TPPP. Reagents and conditions: step a: phosphorylation (i) [(CH3)3CO]2P-
NEt2/DMF/1H-tetrazole; (ii) MCPBA/CH2Cl2;  step b: deprotection (iii) 
HCl/1,4-dioxane; (iv) NaOEt/EtOH. 
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3.1.2. Preparation of stable colloids by optimizing the concentration of 
p-TPPP 
The calcium phosphate nanoparticles were prepared by pumping aqueous 
solutions of Ca(NO3)2·4 H2O (3 mM, pH 9.5) and (NH4)2HPO4 (1.8 mM, pH 
10) into a stirred vessel.[221] A few seconds after mixing, the nanoparticle 
dispersion was taken with a syringe. The colloids were prepared by rapidly 
mixing an aqueous solution of the sodium salt of p-TPPP and the dispersed 
calcium phosphate nanoparticles in a 5 ml:10 ml ratio. A stable colloid was 
prepared by the addition of the sodium salt of p-TPPP (30 µM) solution to 
the dispersed calcium phosphate nanoparticles. The size distribution data 
from dynamic light scattering (DLS) showed an average particle size of 
about 250 nm with a polydispersity index (PDI) ≤ 0.1. The stability of the 
colloidal nanoparticles was followed by DLS. The colloid stored at room 
temperature was stable for about a week, while the colloid stored at 4 to 8 °C 
in refrigerator was stable for about two weeks. Increasing the concentration 
of the sodium salt of p-TPPP to more than 30 µM resulted in a flocculation 
of a green precipitate after 3 hours.  
The unfunctionalized calcium phosphate particles have a slightly positive 
zeta potential of about +1.2 mV at a pH of 8.0.[22] The adsorption of p-TPPP 
(30 µM) reduced the zeta potential to -31.5 mV, which indicates the good 
adsorption of p-TPPP phosphate groups on the calcium phosphate surface.  
Scanning electron microscopy was performed to obtain a direct view on the 
nanoparticles. In the case of the colloid with the addition of 30 µM of p-
TPPP, the SEM picture shows spherical particles with a size of 250 nm (Fig. 
18a), confirming the results from DLS measurements. When increasing the 
concentration of p-TPPP to 60 µM, we found a mixture of spherical particles 
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and long rods (Fig. 18b). A further increase in concentration of p-TPPP gave 
only long rods.  
 
   
 
Figure 18: SEM picture of functionalized calcium phosphate nanoparticles 
after the addition of (a) 30 µM of p-TPPP, and (b) 60 µM of p-TPPP.  
3.1.3. Analyzing the effective functionalization of p-TPPP on the calcium 
phosphate surface 
The stable colloid with 30 µM of p-TPPP was analyzed to determine the 
effective adsorption of p-TPPP on the calcium phosphate surface. The 
functionalized calcium phosphate nanoparticles were separated by 
ultracentrifugation from the dissolved p-TPPP and the counter-ions from the 
calcium phosphate preparation. The amount of dissolved p-TPPP in the 
supernatant was about 30 % as determined by UV spectroscopy, i.e. about 
70 % of the total amount of the added p-TPPP was adsorbed on the calcium 
phosphate surface. The content of p-TPPP in the nanoparticles was estimated 
as follows: If we assume that all calcium and phosphate precipitated as 
hydroxyapatite, Ca5(PO4)3OH, the content of p-TPPP in the solid phase is 
5.52 wt%. If only 70 % of those are adsorbed, the content of p-TPPP 
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decreases to 3.9 wt%. Elemental analysis of the p-TPPP-doped spherical 
nanoparticles by combustion elemental analysis gave 2.32 wt% C and 2.73 
wt% H. As hydrogen can also come from hydroxide groups and from 
adsorbed water, only the carbon content was used. This gave 5.2 wt% of p-
TPPP in the solid. It was concluded that the loading of p-TPPP in the solid 
was around 4-5 wt%. We ascribe the difference between the two methods to 
experimental uncertainties.  
Elemental analysis of the flocculated rod-like particles which were obtained 
at the higher concentration of p-TPPP (0.6 mM) gave 38.12 wt% C and 3.85 
wt% H. Computed from the carbon value,  about 85 % of p-TPPP was 
present in the solid. The calcium salt of p-TPPP can be formed. 
 
 
 
Figure 19: Size distribution data of the redispersed colloid at pH 7.4 from 
dynamic light scattering. 
 
The isolated spherical nanoparticles were easily redispersable in water by 
ultrasonication. The redispersed nanoparticles showed a particle size of 
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about 250 nm with a PDI value 0.023 (Fig. 19), consistent with the dynamic 
light scattering data of the initial colloid, the particles did not change during 
the centrifugation and redispersion. The adsorption of p-TPPP reduced the 
zeta potential to -18.7 mV at a pH of 7.4, which indicates the good 
adsorption of the negatively charged phosphate groups of p-TPPP on the 
calcium phosphate surface. 
Scanning electron microscopy of the redispersed colloid showed spherical 
particles with a size of 250 nm, confirming the results from DLS 
measurements (Fig. 20).  
 
 
 
Figure 20: SEM picture of the redispersed colloidal nanoparticles.  
 
IR data of the sodium salt of p-TPPP and p-TPPP-functionalized calcium 
phosphate nanoparticles are compared in Figure 21. The spectrum of p-
TPPP-functionalized calcium phosphate nanoparticles shows two major 
broad bands at 1057 cm-1 and 577 cm-1 which are assigned to the PO43- 
group in calcium phosphate. The vibrational bands of the sodium salt of p-
 53
TPPP were also observed in the functionalized nanoparticles, confirming 
that the calcium phosphate surface is functionalized by p-TPPP.  
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Figure 21: Comparison of IR data of p-TPPP-functionalized calcium 
phosphate nanoparticles (a) and of the sodium salt of p-TPPP (b). The 
vertical dotted lines correspond to the bands of the sodium salt of p-TPPP. 
 
X-ray powder diffraction data of p-TPPP-functionalized calcium phosphate 
nanoparticles are shown in Figure 22, indicating their almost amorphous 
internal structure.  
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Figure 22: XRD data of p-TPPP-functionalized calcium phosphate 
nanoparticles. The broad peaks indicate a very low crystalline order (note 
that the peak maxima correspond to those of hydroxyapatite). 
 
The absorption spectrum of an aqueous solution of p-TPPP is shown in 
Figure 23. Above pH 8, p-TPPP shows a soret band at 416 nm.[218, 222] The 
protonation of the pyrrole ring (to H4P2+) starts below pH 8 and a red shift of 
the soret band from 416 nm to 438 nm is observed at pH 5 (Fig. 23). The 
change in absorbance in the pH range of 5 to 8 is due to the protonation of 
the pyrrole base. A pronounced decrease in absorbance is observed below 
pH 1 and above pH 12 which is due to the precipitation of the corresponding 
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salt of p-TPPP.[218] Taking this effect into account, a pH between 5 and 10 
was chosen for all UV experiments.  
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Figure 23: UV-vis spectra of 6 µM of p-TPPP in water at pH 9 (a) and at pH 
5 (b). 
 
Figure 24a shows the absorption spectrum of the redispersed colloid at pH 
7.4. It has a soret band at 417 nm with a shoulder at 440 nm. In the Q band 
region, a new broad band occurs at 663 nm. Figure 24b shows the aqueous 
solution of p-TPPP at pH 7.4 where it exists as a partially protonated form 
with the soret bands at 417 nm and 442 nm, and the Q bands at 520 nm, 560 
nm, 584 nm, 641 nm and 672 nm. Comparing the spectrum of the 
redispersed colloid with the free p-TPPP at pH 7.4, the shift of the soret 
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bands and Q bands to the base form of p-TPPP (H2P) and the slight increase 
of the baseline towards the lower wavelength of the spectrum indicate the 
adsorption of p-TPPP on the calcium phosphate surface.  
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Figure 24: UV-vis spectra of the redispersed colloid (effective concentration 
of p-TPPP: 10±2 µM) (a) and of an aqueous solution of p-TPPP (10 µM) 
(b), both at pH 7.4. 
 
At an excitation wavelength of 410 nm, the emission spectrum of the 
redispersed colloid consists of a strong band at 653 nm with a shoulder at 
705 nm (Fig. 25). At pH 7.4, the partially protonated form of p-TPPP shows 
two strong bands at 650 nm and 712 nm in the emission spectrum (Fig. 25). 
This spectrum was compared with the emission spectrum of the redispersed 
 57
colloid. In the case of the redispersed colloid, a broad shoulder was observed 
at 705 nm, instead of a strong peak at 712 nm. The observed spectral 
changes in the absorption and emission spectra of the redispersed colloid are 
probably caused by the electrostatic interaction of p-TPPP with the calcium 
phosphate surface.  
600 650 700 750 800 850
0
2000
4000
6000 λex = 410 nm
 p-TPPP
 Colloid
 
 
Fl
uo
re
sc
en
ce
 In
te
ns
ity
λ / nm
 
Figure 25: Comparison of fluorescence emission spectra of the redispersed 
colloid (effective concentration of p-TPPP: 10±2 µM) and of an aqueous 
solution of p-TPPP (10 µM) at pH 7.4. 
 
The emission spectrum of the solid p-TPPP-functionalized calcium 
phosphate nanoparticles was also measured. The particles were excited in 
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the near UV region at 306 nm (Fig. 26). The emission spectrum showed two 
strong peaks at 472 nm and 597 nm. 
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Figure 26: Fluorescence emission spectrum of solid p-TPPP-functionalized 
calcium phosphate nanoparticles. 
 
3.1.4. Experiments with NIH 3T3 fibroblast cell culture 
In the cooperation with the Chair of Molecular Neurochemistry, University 
of Bochum and Ms. Anna Kovtun, cell culture studies were carried out. The 
biocompatibility of the functionalized nanoparticles was studied with an 
NIH 3T3 fibroblast cell culture. An MTT test confirmed the absence of 
toxicity (Fig. 27). Similar results were obtained for longer incubation times 
(24 and 48 h). 
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Figure 27: Results of the MTT test after 7 h incubation with p-TPPP-
functionalized calcium phosphate nanoparticles. The decrease in the cell 
vitality is not statistically significant. 
 
The functionalized nanoparticles were readily taken up by cells. This could 
be shown by transmission fluorescence microscopy (Fig. 28). p-TPPP shows 
a strong red fluorescence which is both widely distributed inside the cells, 
indicating a partial dissolution of the nanoparticles under release of the dye. 
This gives a red fluorescing background which also shows the cell contours. 
This confirms that the nanoparticles were taken up by the cells and had 
partially dissolved. Because the cells were washed twice with PBS before 
fluorescence microscopy, the medium which also contained dissolved dye 
and dispersed nanoparticles was removed, i.e. we see only the dye within the 
cells (and possibly a small amount adsorbed on the cell surface). By 
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changing the contrast, it is possible to highlight the individual nanoparticles 
inside the cells as dark-red dots. The extended cell morphology confirms 
their healthy state in the presence of the nanoparticles. 
 
   
 
Figure 28: Fluorescence (A) and transmission light (B) microscopy of NIH 
3T3 fibroblast cells after 7 h incubation with p-TPPP-functionalized calcium 
phosphate nanoparticles. C shows an overlay of A and B after removal of 
the background. In this case, only the nanoparticles are visible (see text). 
 
By confocal laser scanning microscopy, it was shown that the red 
fluorescing nanoparticles are in fact present inside the cells and not just 
adsorbed on their surface. A series of horizontal cuts through one cell is 
shown in Figure 29. 
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Figure 29: A series of horizontal cuts through a cell, recorded with a 
confocal laser scanning microscope, 48 h after incubation with p-TPPP-
functionalized calcium phosphate nanoparticles. It clearly shows that the red 
fluorescing nanoparticle is present inside the cell. Left: Transmission light 
microscopy; Centre: Confocal fluorescence microscopy. Right: Overlay of 
light microscopy and confocal fluorescence microscopy. 
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3.1.5. Conclusions 
We have prepared stable colloids of calcium phosphate nanoparticles by 
coating their surface with a phosphate-functionalized porphyrin (p-TPPP). 
The dye is the only agent needed for colloidal stabilization, and no other 
compounds are present. The spherical particles have a diameter of about 250 
nm and consist of poorly crystalline calcium phosphate with a loading of 4-5 
wt% of porphyrin. The photophysical properties of the redispersed colloid 
confirm the electrostatic interaction of p-TPPP with the calcium phosphate 
surface and demonstrate its good fluorescence in the visible region of the 
spectrum. The uptake of the nanoparticles into NIH 3T3 fibroblast cells 
occurs after a few hours, and the dye is released into the cytoplasm by 
dissolution of the nanoparticle. No adverse effects on the cells were 
observed. The nanoparticles may therefore be used as fluorescing agents and 
(even more interesting) for the delivery of the fluorescing dye into the cell. 
As a carrier into the cell, the porphyrin-loaded nanoparticle has the 
advantages that it can be easily taken up by cells. They transport a 
considerable amount of dye into the cell and dissolve into the harmless 
byproducts calcium and phosphate. A size of nanoparticles of about 100-300 
nm was shown to be efficient in photodynamic therapy.[223-225] Therefore, a 
good performance in photodynamic therapy is expected. 
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3.2. Synthesis and characterization of calcium phytate 
nanoparticles from calcium phosphate nanoparticles 
Phytic acid, myo-inositol-1,2,3,4,5,6-hexakis phosphate is a member of the 
isomer family of 1,2,3,4,5,6-hexakis(phosphate) cyclohexane with a six-fold 
substitution of phosphate. Therefore, it is characterized by a high density of 
phosphate groups which are able to interact with a calcium phosphate 
surface. It is also an abundant biomolecule in humans, animals and plants 
and therefore of high biocompatibility.[177, 179] By its six phosphate groups, it 
has a strong chelating effect to bind multivalent cations which can lead to an 
undesired depletion of metals like Zn2+, Fe2+/3+, Ca2+, Mg2+, Mn2+, and Cu2+ 
in the body.[179, 226] With calcium ions, it immediately forms an insoluble 
salt, i.e. calcium phytate.  
Calcium phytate is also an effective absorbent for heavy metals like lead.[227, 
228] An in-situ precipitation of calcium phytate is used together with 
radioactive markers as dispersion for scintigraphy in the liver and spleen[229-
232] and also commercially available as kit.[231] However, the particle size is 
about 100-300 nm and the stability of the dispersion is only about 6 h at 
room temperature.[231] Calcium phytate particles are unstable in solution. 
They tend to agglomerate and precipitate immediately.  
A method of preparation of colloids of calcium phytate nanoparticles is 
described in the present study. Synthetically prepared calcium phosphate 
nanoparticles are reacted with sodium phytate, leading to an anion exchange 
in the surface and thereby to stable calcium phytate nanoparticles which may 
be used, e.g., for scintigraphy, as food additive or as additive to dental-care 
formulations. In this method, the calcium phosphate nanoparticles were used 
as nuclei. 
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3.2.1. Optimizing the concentration of phytic acid to prepare the stable 
colloids of calcium phytate nanoparticles 
Calcium phosphate nanoparticles were prepared by rapidly pumping 
aqueous solutions of Ca(NO3)2·4 H2O (3 mM and 18 mM, pH 9) and 
(NH4)2HPO4 (1.8 and 10.8 mM, pH 9) with an equal volume rate into a 
stirred vessel.[233] The ratio of calcium to phosphate (5:3) always 
corresponded to that in hydroxyapatite, Ca5(PO4)3OH, i.e. the calcium 
phosphate which is formed under  these conditions.[2] A few seconds after 
mixing, the dispersed calcium phosphate nanoparticles were taken with a 
syringe. The colloids were then prepared by rapidly mixing an aqueous 
solution of dodecasodium phytate (Na12PA) and the dispersed calcium 
phosphate nanoparticles in a 10 ml:10 ml ratio. The concentration of the 
sodium phytate solution was varied from 0.06 mM to 10.8 mM. Due to this 
mixing and dilution process, the effective concentrations of Ca2+ were 0.75 
and 4.5 mM, of PO43- 0.45 and 2.7 mM, and of sodium phytate 0.03 to 5.4 
mM. The final pH of the colloid was between 8 and 9. The particles were 
studied either as dispersion or after collection on a membrane filter (supra®-
100 by PALL Life sciences). The filtered nanoparticles were washed with 
100 ml of absolute ethanol and dried in air. Ultrapure water (Purelab ultra 
instrument from ELGA) was used for all preparations.  
Hexacalcium phytate (Ca6PA) was prepared by pumping aqueous solutions 
of Ca(NO3)2·4 H2O (18 mM, pH = 9.5) and sodium phytate (3 mM, pH = 
10.5) into a stirred vessel which led to immediate precipitation. After 30 
minutes stirring the precipitate was collected by filtration. The powder was 
washed with ethanol and dried in air at 37 °C.  
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Figure 30: Schematic view of the exchange of phosphate by phytate on the 
surface of nanoparticles (left hand scheme), preventing the immediate 
precipitation of calcium phytate (right hand scheme). The colloidal 
stabilization of the calcium phytate nanoparticles is due to their strongly 
negative charge. 
 
Calcium phosphate nanoparticles were prepared by rapid precipitation from 
aqueous solution and rapidly mixed with a solution of sodium phytate. By 
this procedure, the immediate precipitation of calcium phytate as insoluble 
salt was prevented, probably by adsorption of negatively charged phytate 
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anions on the calcium phosphate surface. This led to a strongly negative 
charge which prevented further agglomeration. The calcium phosphate 
particles thereby served as template for the precipitation of calcium phytate. 
The phosphate anions are then exchanged by phytate anions as it will be 
shown below. The tentative mechanism is depicted in Figure 30. 
Stable particles were only obtained in a narrow concentration range of 
calcium phosphate to sodium phytate (Table 2).  
 
Table 2: Properties of calcium phytate colloids from dynamic light 
scattering (DLS) and scanning electron microscopy (SEM). In all cases, the 
effective concentrations in the solution after mixing and dilution are given. 
Polydispersity index (PDI) value was obtained from DLS measurement. 
[Ca2+] 
/ mM 
[PO43-] 
/ mM 
[phytate] 
/ mM 
[Ca2+] : 
[phytate] 
Particle 
size from 
DLS / 
nm 
PDI 
Zeta 
potential 
/ mV 
Particle size 
by SEM / 
nm 
4.5 2.7 0.03 150 : 1 >1000  - -6 (4) only 
agglomerates 
were found 
4.5 2.7 0.3 15 : 1 >1000  - -22 (4) 
4.5 2.7 0.9 5 : 1 >1000  - -43 (5) 
4.5 2.7 1.8 2.5 : 1 297 0.193 -52 (6) ca. 250 
0.75 0.45 0.3 2.5 : 1 60 0.209 -56 (6) ca. 30-40 
4.5 2.7 3 1.5 : 1 148 0.144 -52 (10) ca. 100 
4.5 2.7 3.6 1.25 : 1 184 0.120 -50 (10) very few 
particles 
were found 
4.5 2.7 4.5 1 : 1 > 500  - -37 (13) 
4.5 2.7 5.4 0.83 : 1 > 500  - -43 (5) 
 
A molar ratio of Ca2+ to phytate between 2.5:1 and 1.25:1 gave the best 
results. If the ratio of calcium to phytate was higher, only agglomerated 
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nanoparticles which gave a precipitate were found, probably due to 
insufficient electrostatic stabilization. If it was smaller, only a very small 
amount of particles was found, probably due to the formation of soluble 
calcium-phytate complexes. In the optimal range, the particles had the 
highest negative charge; therefore it was concluded that the nanoparticles 
were stabilized by electrostatic repulsion. The colloids were stable for about 
two weeks at room temperature before first signs of sedimentation occurred. 
 
Figure 31: Size distribution data from dynamic light scattering (DLS) of 
calcium phytate nanoparticles prepared with (a) [Ca2+] = 4.5 mM and 
[phytate] = 1.8 mM, (b) [Ca2+] = 4.5 mM and [phytate] = 3 mM and (c) 
[Ca2+] = 0.75 mM and [phytate] = 0.3 mM. 
 
Figure 31 shows the dynamic light scattering data for the stable colloidal 
dispersions. Scanning electron microscopy showed the morphology and size 
of the functionalized calcium phosphate particles (Fig. 32), confirming the 
data from dynamic light scattering. All particles are approximately spherical 
and their size is very uniform under a given set of conditions. 
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Figure 32: SEM pictures of calcium phytate nanoparticles prepared with (a) 
[Ca2+] = 4.5 mM and [phytate] = 1.8 mM, (b) [Ca2+] = 4.5 mM and [phytate] 
= 3 mM, (c) [Ca2+] = 0.75 mM and [phytate] = 0.3 mM, and (d) [Ca2+] = 4.5 
mM and [phytate] = 0.9 mM (agglomerated sample). 
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Figure 33: IR spectra of aggregated calcium phosphate particles prepared 
with [Ca2+] = 4.5 mM and [phytate] = 0.5 mM (a), of calcium phytate 
nanoparticles prepared with [Ca2+] = 4.5 mM and [phytate] = 3 mM, 
obtained by filtration (b), and of precipitated calcium phytate (c).  
 
Figure 33 shows the IR spectra of functionalized calcium phosphate 
nanoparticles, isolated calcium phytate nanoparticles and precipitated 
calcium phytate particles. The characteristic vibrational bands of 
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hydroxyapatite (1105, 1036, 602, and 563 cm-1) were detected only at a high 
ratio of Ca2+ to phytate (> 5:1), i.e. when agglomerates were formed (Table 
2). The characteristic vibrational bands of the phytic acid were also observed 
(997, 897,849, and 793 cm-1), indicating the presence of adsorbed phytic 
acid in the agglomerated particles (Fig. 33a). 
The IR spectrum of the calcium phytate nanoparticles is shown in Figure 
33b which consists of characteristic vibrational bands of calcium phytate 
(Fig. 33c). The adsorbed water molecules give a weak absorption band 
around 1645 cm-1 (bending) and a broad absorption band around 3400 cm-1 
(stretching vibration).  Two broad bands around 1130 and 542 cm-1 are 
assigned to the PO42- group. The bands at 991, 903, 843 and 795 cm-1 are 
assigned to the C-O-P vibrations from the 5ax/1eq conformation of 
phytate[234]. The C-O stretching vibration is observed at 1398 cm-1. 
Compared to precipitated calcium phytate, the small shifts in the vibrational 
bands of functionalized particles are probably due to different calcium 
concentrations in the samples.  
X-ray powder diffraction showed that the calcium phytate nanoparticles 
were X-ray amorphous like the precipitated calcium phytate (Fig. 34a and 
34b). Only for agglomerated samples with a high Ca2+ to phytate ratio (>5:1) 
we observed broad diffraction peaks of hydroxyapatite (Fig. 34c), which 
indicates the lower crystallinity of the calcium phosphate nanoparticles. 
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Figure 34: XRD data of calcium phytate nanoparticles prepared with [Ca2+] 
= 4.5 mM and [phytate] = 3 mM, obtained by filtration (a), and of 
precipitated calcium phytate (b). The samples were almost fully amorphous. 
The XRD spectrum of agglomerated particles obtained with [Ca2+] = 4.5 and 
[phytate] = 0.5 mM (c). The broad diffraction peaks indicate the poorly 
crystalline nature of hydroxyapatite phase. The expected diffraction pattern 
for hydroxyapatite is shown at the bottom for reference (black line). 
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Table 3: Elemental analysis data of calcium phosphate/calcium phytate 
colloids, obtained by filtration and drying in air at 37 °C. CaP = calcium 
phosphate. 
[Ca2+] / 
mM 
[PO43-] / 
mM 
[phytate] / 
mM 
C / 
% 
H / 
% 
Ca / 
% 
Composition 
4.5 2.7 0.05  0.84 1.16 33.55 CaP+Ca6PA+H2O
4.5 2.7 0.5 2.55 1.93 29.38 CaP+Ca6PA+H2O
4.5 2.7 1.5  6.10 2.81 19.75 Ca6PA+H2O
4.5 2.7 3.0 7.13 2.89 21.08 Ca6PA+H2O
0.75 0.45 0.3 6.74 2.65 21.39 Ca6PA+H2O
Precipitated calcium phytate 6.43 3.45 21.26 Ca6PA+H2O
Computed for Ca6PA·13.1 H2O 6.41 2.89 21.39  
Computed for calcium phytate 
(Ca6PA) 
8.11 0.68 27.07  
 
By elemental analysis, it was confirmed that the particles consist of 
hexacalcium phytate plus some adhering water (about 21 wt%), except for 
high ratios of calcium to phytate where calcium phosphate was still present. 
In these cases, the exchange of phosphate by phytate was not quantitative. 
Attempts to determine the content of phosphate as molybdate complex gave 
no satisfactory results, probably because the organic phosphate in the 
phytate was only partly susceptible to this reaction. The data from elemental 
analysis were qualitatively confirmed by energy-dispersive X-ray 
spectrometry in the SEM. 
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3.2.2. Conclusion 
The direct synthesis of calcium phytate by mixing a calcium salt and a 
phytate salt does not lead to a stable colloid, probably due to aggregation 
and crystal growth. If calcium phosphate nanoparticles are used as nuclei, 
the phosphate anion is exchanged by phytate and a stable colloid of calcium 
phytate can be obtained. However, the ratio of calcium to phytate must be in 
a narrow range around 1.5:1. If calcium phosphate is present in excess, the 
particles still contain calcium phosphate and precipitation occurs. If phytate 
is present in excess, dissolution of the particles occurs, probably by 
complexation of calcium by phytate ions. These colloids have the major 
advantage of being fully biocompatible with no stabilizers being necessary. 
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3.3. Synthesis and characterization of hollow calcium 
phosphate nanoparticles 
Hollow calcium phosphate shells have attracted considerable interest within 
the last ten years due to their good biodegradability and biocompatibility, 
their wide application as bioceramics, as an adsorbent for biomaterials and 
as chemical sensor, catalyst supports, bone-repairing agent, biomedical 
implants and drug delivery vehicles.[91, 94, 95, 235] Template-assisted or 
template-free methods were used to prepare hollow calcium phosphate 
micro- and nanoparticles. Mostly the hollow calcium phosphate particles are 
prepared by template-assisted methods, including hard templates (polymeric 
capsules[95, 236], polymeric nanotemplates[94], lithium-calcium-borate glass[100, 
101], plasma-spraying on metallic substrate[237] and spray pyrolyzing[238]) and 
soft templates (aerosol-mediated approach[105], surfactants and emulsions[104, 
106, 107, 112, 113, 239]).  
Bigi et al. reported the template-free self-assembly method to prepare hollow 
octacalcium phosphate microstructures (spherulite-like structure consist of 
blade-shaped octacalcium phosphate crystals) using polyaspartate or 
polyacrylate as additive.[240, 241] 
An easy and convenient template-free method to prepare hollow calcium 
phosphate nanoparticles is demonstrated in the current study by 
functionalizing dispersed calcium phosphate nanoparticles with O-phospho-
L-tyrosine (TyrP).  
TyrP has three different functional groups (-NH2, -COOH, and -OPO3H2) 
which are all unprotected. TyrP is known to increase the activity of protein 
tyrosine phosphatases and inhibit the epidermal growth factor receptor 
activity which results in the inhibition of growth of cancer cells.[188, 190-192] 
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3.3.1. Synthesis of O-phospho-L-tyrosine (TyrP). 
Optically pure O-phospho-L-tyrosine (TyrP) was prepared according to the 
reported procedure (Fig. 35).[242] The isolated compound was characterized 
by 31P-, 13C-, 1H-NMR, IR, elemental analysis, and ESI-MS data.  
 
H2O3PO
L-tyrosine
O
NH2HO
HO
O
NH2HO
O-phospho-L-tyrosine
P4O10/H3PO4 (85%)
ref lux for 24 hours, 80°C
 
 
Figure 35: Schematic diagram illustrating the synthesis of O-phospho-L-
tyrosine (TyrP). 
 
3.3.2. Influence of the concentration of TyrP on the morphology of the 
calcium phosphate nanoparticles 
The calcium phosphate nanoparticles were prepared by simultaneously 
pumping aqueous solutions of Ca(NO3)2·4H2O (3 mM, pH 9) and 
(NH4)2HPO4 (1.8 mM, pH 9) into a stirred vessel. A few seconds after 
mixing, the nanoparticle dispersion was taken with a syringe. The colloids 
were prepared by rapidly mixing an aqueous solution of TyrP (pH 9) and the 
dispersed calcium phosphate nanoparticles in a 5 ml:10 ml ratio. Before 
preparing the colloids, the solutions of TyrP were filtered through a syringe 
filter to remove dust particles. The colloid was gently swirled for few 
seconds. The concentration of TyrP solution was varied from 0.3 to 6 mM. 
Due to this mixing and dilution process, the effective concentrations were 
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[Ca2+] = 1 mM, [PO43-] = 0.6 mM, and [TyrP] = 0.1 to 2 mM.  The final pH 
of the colloid was between 7.5 to 8.5. The particles were studied either as 
dispersion or after collection on a membrane filter (supra®-100 by PALL 
Life sciences). The filtered nanoparticles were washed with 100 ml of 
absolute ethanol and dried in air. Ultrapure water (Purelab ultra instrument 
from ELGA) was used for all preparations. The fresh colloids were 
immediately studied by dynamic light scattering. 
 
Table 4: Properties of calcium phosphate colloids from dynamic light 
scattering (DLS) and scanning electron microscopy (SEM). In all cases, the 
effective concentrations in the solution after mixing and dilution are given. 
The polydispersity index (PDI) was obtained from DLS measurement. 
[Ca2+] 
/ mM 
[PO43-] / 
mM 
[TyrP] 
/mM 
[Ca2+]/
[TyrP] 
Particle 
size 
from 
DLS / 
nm 
PDI 
Zeta 
potential / 
mV 
Morphology; 
particle size by 
SEM / nm 
1 0.6 0.1 10:1 359 0.176 -9 (4) 
Flower-like 
particles; 
> 1000 
1 0.6 0.3 3:1 255 0.110 -14 (5) 
A mixture of 
spherical and 
needle-like 
particles;  
ca. 250 
1 0.6 0.5 2:1 241 0.083 -20 (5) 
Hollow 
spherical 
particles; 
ca. 250 
1 0.6 0.7 1.43:1 219 0.090 -18 (6) 
1 0.6 1 1:1 237 0.055 -21 (5) 
1 0.6 2 0.5:1 232 0.105 -27 (6) 
 
 
All properties of the colloids from dynamic light scattering measurements 
are shown in Table 4. A stable colloid could be prepared at a low Ca2+ to 
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TyrP ratio (≤ 1:1). The zeta potential value was about -20 to -30 mV, 
indicating the adsorption of negatively charged TyrP on the calcium 
phosphate surface.  
With a high Ca2+ to TyrP ratio (≥ 10:1), the aggregation of particles occurred 
within few minutes, probably due to less electrostatic stabilization of the 
calcium phosphate particles. Figure 36 shows the dynamic light scattering 
data of TyrP-functionalized calcium phosphate nanoparticles (Ca2+:TyrP = 
1:1). The colloids were stable for three to four hours. When the Ca2+ to TyrP 
ratio was decreased to less than 1, the colloids were stable for about 24 hours 
at room temperature before first signs of sedimentation occurred.   
 
 
 
 
Figure 36: Size distribution data of the TyrP-functionalized calcium 
phosphate nanoparticles (Ca2+:TyrP = 1:1) from dynamic light scattering 
without sonication at pH 8.3. 
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Figure 37: SEM pictures of TyrP-functionalized calcium phosphate 
nanoparticles prepared with a Ca2+ to TyrP ratio of (a) 10:1, (b) 3:1 (the 
arrows indicate the aggregation of needle-like particles), (c) 2:1, (d) 2:1 after 
60 minutes sonication, (e) 1:1 and (d) 1:1 after 60 minutes sonication. 
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Scanning electron microscopy shows the morphology and size of the TyrP-
functionalized calcium phosphate particles (Fig. 37). With high Ca2+ to TyrP 
ratio (≥ 10:1), the aggregated flower-like microparticles were observed (Fig. 
37a). At the Ca2+ to TyrP ratio of 3:1, a mixture of spherical and needle-like 
particles was observed. From the detailed analysis of the SEM picture (Fig. 
37b), the spherical particles could be formed by the aggregation of needle-
like particles. By lowering the Ca2+ to TyrP ratio (≤ 2:1), only the hollow 
spherical nanoparticles were observed, in which the monolayer of the 
calcium phosphate shell consisted of 20 to 30 nm primary nanoparticles 
(Fig. 37c and 37e). The SEM results were in good agreement with the 
dynamic light scattering data. 
The stability of hollow nanoparticles was checked by continuous 
ultrasonication (35 Hz, 160 W, Bandelin Sonorex® RK510). The fresh 
colloids were sonicated for 60 minutes. The final temperature of the water in 
the ultrasonic bath was between 45 to 55°C. When the Ca2+ to TyrP ratio 
was 2:1, the hollow spherical particles were transformed to aggregated 
needle-like particles (Fig. 37d). In the case of lower Ca2+ to TyrP ratio (1:1), 
most of the hollow spherical particles were broken and primary calcium 
phosphate nanoparticles (20-30 nm) were formed (Fig. 37f). Some hollow 
spherical particles were still found. This shows that the hollow particles are 
stable at room temperature (without any mechanical agitation), when the 
Ca2+ to TyrP ratio is ≤ 2. It also displays that the formation of hollow 
nanoparticles is highly influenced by the amount of TyrP used to 
functionalize the calcium phosphate nanoparticles.  
The isolated hollow particles were calcined at 600°C in air for 10 minutes 
and cooled to room temperature. The calcined particles were analyzed 
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through SEM which showed that the hollow spherical particles were stable 
during calcination (see Fig. 38).  
 
 
 
Figure 38: SEM picture of hollow spherical particles after calcination 
(Ca2+:TyrP = 1:1). 
 
X-ray powder diffraction data of TyrP-functionalized calcium phosphate 
nanoparticles are shown in Figure 39. Figures 39a, 39c and 39d show two 
broad diffraction peaks, indicating the amorphous internal structure of the 
samples. The diffraction peaks of hydroxyapatite were observed only at 
higher Ca2+ to TyrP ratio (2:1), when the nanoparticles were collected after 
60 minutes sonication. The width of the diffraction peaks indicates the 
poorly or moderately crystalline phase of hydroxyapatite (Fig. 39b). 
Comparing these XRD data with SEM pictures (Fig. 37c, 37d, 37e and 37f), 
the hollow spherical particles are X-ray amorphous and the aggregated 
needle-like particles are poorly crystalline hydroxyapatite. 
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Figure 39: XRD data of the hollow calcium phosphate nanoparticles 
prepared with a Ca2+ to TyrP ratio of (a) 2:1, (b) 2:1 after 60 min sonication, 
(c) 1:1 and (d) 1:1 after 60 minutes sonication. The expected diffraction 
pattern for hydroxyapatite is shown at the bottom for reference (black line). 
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Figure 40: IR data of the functionalized calcium phosphate nanoparticles 
prepared with [Ca2+]/[TyrP] of (a) 2:1 (hollow spherical particles), (b) 2:1 
after 60 min sonication (needle-like particles) and (c) 1:1 (hollow spherical 
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particles). The arrows indicate the weak absorption bands of TyrP. (d) IR 
spectrum of TyrP for reference.  
In Figure 40, IR data of TyrP-functionalized calcium phosphate 
nanoparticles and TyrP are compared. The adsorbed water molecules gave a 
weak absorption band around 1645 cm-1 (bending) and a broad absorption 
band around 3400 cm-1 (stretching vibration). The weak C-O bending 
vibration of carbonate group was observed at 1385 cm-1. Figure 40a and 40c 
show two broad vibrational bands at 1057 cm-1 and 577 cm-1 which are 
assigned to the PO43- group in calcium phosphate. The characteristic 
vibrational bands of hydroxyapatite (1038, 604, and 565 cm-1) were 
observed only for the sample collected after 60 minutes sonication 
(Ca2+/TyrP = 2:1) (Fig. 40b). The very weak vibrational bands of TyrP were 
also observed at 2982 cm-1, 2853 cm-1, 1504 cm-1 and 876 cm-1, confirming 
that the calcium phosphate surface is functionalized by TyrP.  
Table 5 shows the elemental analysis data of TyrP-functionalized calcium 
phosphate nanoparticles. The content of TyrP in the nanoparticles was 
estimated as follows: The hollow nanoparticles consist of about 74-83% of 
calcium phosphate. About 18 % of water molecules could be adhered in the 
amorphous sample. It is concluded that the effective loading of TyrP in the 
solid is around 3-6 wt%, if we assume that all calcium and phosphate did 
precipitate as hydroxyapatite, Ca5(PO4)3OH. Therefore, an excess amount of 
TyrP is present in solution which influences the formation of hollow calcium 
phosphate nanoparticles.  
The porosity of the hollow particles was about 0.4 to 0.5, which was 
computed from the ratio of the volume of void space in the material and the 
volume of the total or bulk material.  
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Table 5: Elemental analysis data of TyrP-functionalized calcium phosphate 
nanoparticles, obtained by filtration and drying in air at 37 °C.  
[Ca2+] 
/ mM 
[PO43-] 
/ mM 
[TyrP] 
/ mM 
So
ni
ca
tio
n 
(m
in
) 
C / 
% 
H / 
% 
Ca / 
% 
1 P
er
ce
nt
ag
e 
of
 T
yr
P 
 
2 P
er
ce
nt
ag
e 
of
 
ca
lc
iu
m
 p
ho
sp
ha
te
  
3 P
er
ce
nt
ag
e 
of
 
w
at
er
  
1 0.6 0.5 - 1.32 1.99 - 3.19 - 16.5 
1 0.6 0.5 60 2.48 1.27 33.1 5.99 83.1 8.8 
1 0.6 1 - 0.92 2.16 29.54 2.22 74.2 18.4 
 
1Computed from the amount of carbon by the ratio of the molar masses of 
carbon and TyrP. 
2Computed from the amount of calcium by the ratio of the molar masses of 
calcium and hydroxyapatite. 
3Computed from the amount of hydrogen by the ratio of the molar masses of 
hydrogen and water. 
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3.3.3. Conclusion 
A template-free method of preparation of hollow calcium phosphate 
nanoparticles was described. The method is simple and efficient and the 
hollow particles are easily prepared by mixing the dispersed calcium 
phosphate nanoparticles with TyrP. The zeta potential values indicate the 
adsorption of TyrP on the calcium phosphate surface. SEM measurements 
showed hollow spherical nanoparticles with a size of ca. 250 nm which was 
supported by dynamic light scattering data. The size and hollow spherical 
structure of the particles were unaffected by increasing the concentration of 
calcium to TyrP ratio to more than 2:1. The hollow spherical particles are 
composed of a thin shell of primary calcium phosphate nanoparticles. The 
thickness of the cell is about ca. 20-30 nm. The presence of hollow spherical 
particles was confirmed by calcining the isolated hollow particles at 600°C. 
By comparing the SEM and XRD data, it was concluded that the hollow 
spherical structures consist of amorphous particles. Although a higher 
concentration of TyrP ([Ca2+]/[TyrP] = 1) was used to functionalize the 
calcium phosphate particles, only very weak vibrational bands were 
observed in IR spectroscopy of the TyrP-functionalized calcium phosphate 
particles. The effective concentration of TyrP in the solid calcium phosphate 
particles was around 3-6%.  
Therefore, the amount of free TyrP present in solution plays a critical role in 
the formation of hollow structures. The surface adsorbed TyrP molecules 
may have free functional groups, most probably –NH2 or –COOH groups. 
The presence of an excess amount of TyrP in solution could have weak 
interactions (like hydrogen bonding) with surface adsorbed TyrP molecules 
which results in the self-assembly of  primary calcium phosphate particles 
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(ca. 20-30 nm) into hollow spherical particles (ca. 250 nm). By sonication of 
the colloids, the weak hydrogen bonding can be broken and the hollow 
spherical nanoparticles can be transformed into needle-like particles. These 
biocompatible TyrP-functionalized calcium phosphate nanoparticles may be 
useful in drug delivery systems. 
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3.4. Functionalization of calcium phosphate nanoparticles with 
alkyl phosphates 
In the current study, calcium phosphate nanoparticles were functionalized 
with alkyl phosphates (surfactants) which have phosphate as head group and 
alkyl chains as tail groups. Alkyl phosphates were varied in their length of 
the alkyl chain or the spacer groups attached with them. In two surfactants, 
namely dodecyloxyphenyl phosphate and dodecyloxybiphenyl phosphate, 
aryl groups were used as spacer groups between head and tail groups. 
 
3.4.1. Represented alkyl phosphates 
The alkyl phosphates shown in Figure 41 were synthesized, characterized 
and used to functionalize the calcium phosphate surface. 
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Figure 41: Chemical structure, name and abbreviation of alkyl phosphates 
which were used to functionalize the calcium phosphate particles. 
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3.4.2. Synthesis of alkyl phosphates 
Okamoto et al. reported an easy and convenient method to prepare 
monoalkyl dihydrogen phosphates by treating the alcohols with 
trimethylsilyl polyphosphate (Fig. 42).[243]  In the present study, DDP, TDP 
and ODP were prepared according to this procedure. Trimethylsilyl 
polyphosphate is prepared by refluxing a benzene solution of diphosphorus 
pentaoxide and hexamethyldisiloxane. The reaction proceeds smoothly with 
a high yield of monoalkyl dihydrogen phosphate and only trace amounts of 
dialkyl hydrogen phosphate.  
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Figure 42: Schematic diagram illustrating the preparation of DDP, TDP and 
ODP. 
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The above procedure was tried to prepare DDOPhP and DDOBPhP but the 
reactions were not successful. Therefore the corresponding alcohol groups 
were directly treated with POCl3 in the presence of triethylamine or pyridine 
as base (Fig. 43). The products were recrystallized in hot n-hexane. The 
yield was very poor for DDOPhP and DDOBPhP compared to DDP, TDP 
and ODP. 
 
 
 
Figure 43: Schematic diagram illustrating the preparation of DDOPhP and 
DDOBPhP. 
 
3.4.3. Optimizing the concentrations of alkyl phosphates to functionalize 
the calcium phosphate surface 
The calcium phosphate nanoparticles were prepared by pumping aqueous 
solutions of Ca(NO3)2·4 H2O (3 mM, pH 9.5) and (NH4)2HPO4 (1.8 mM, pH 
10) into a stirred vessel. A few seconds after mixing, the nanoparticles 
dispersion was taken with a syringe. The colloids were prepared by rapidly 
mixing an aqueous solution of the sodium salt of alkyl phosphates and the 
dispersed calcium phosphate nanoparticles in a 10 ml:10 ml ratio. The 
concentration of the sodium salt of the alkyl phosphate solution was varied 
from 25 µM to 100 µM. After mixing of the alkyl phosphate with the 
calcium phosphate nanoparticle dispersion, the colloid was immediately 
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studied by the dynamic light scattering (DLS) measurement. The 
polydispersity index (PDI) value (<0.3) was used to confirm the 
monodisperse behaviour of colloidal systems.  
In the case of the sodium salt of TDP (25 µM), the size distribution data 
from DLS showed an average particle size of about 650 nm with a PDI value 
of 0.124 (Fig. 44). The adsorption of the sodium salt of TDP reduced the 
zeta potential to -33 mV (Table 2), which indicates the good adsorption of 
TDP phosphate head groups on the calcium phosphate surface.  
 
 
 
Figure 44: Size distribution data of calcium phosphate nanoparticles 
functionalized with 25 µM of the sodium salt of TDP at pH 8 from dynamic 
light scattering.  
 
The aggregation behavior of the colloidal particles was studied by DLS 
measurement (Fig. 45). The particles aggregated slowly with time. The size 
of the particle grew from 650 nm to more than 1 µm, and the PDI value was 
almost 0.3. The colloid was stable only for three hours at room temperature 
before first signs of sedimentation occurred.  
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Figure 45: Aggregation behavior of the colloidal particles in the case of 
TDP at pH 8. 
 
By increasing the TDP concentration to 50 µM, the average size of the 
particles was reduced to 531 nm but the PDI value was greater than 0.3. This 
indicated that the particles were not monodisperse. A further increase in the 
concentration of TDP to more than 50 µM resulted in immediate 
flocculation.  
Scanning electron microscopy (SEM) was performed to obtain a direct view 
on the nanoparticles (Fig. 46). In the case of the colloid with the addition of 
25 µM and 50 µM of TDP, the SEM picture showed flower-like aggregated 
micro particles. By increasing the concentration to more than 50 µM, rod-
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like particles were observed. The length of the rod-like particles was about 1 
to 2 µm and the diameter was about 100 to 200 nm. 
 
  
  
Figure 46: SEM picture of calcium phosphate particles functionalized by the 
addition of (a) 25 µM, (b) 50 µM, (c) 75 µM and (d) 100 µM of the sodium 
salt of TDP. 
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3.4.4. Comparison of the sodium salt of TDP with other surfactants or 
alkyl phosphates in functionalizing the calcium phosphate surface 
The dynamic light scattering data and SEM results of TDP-functionalized 
calcium phosphate particles were compared with the data of other alkyl 
phosphate-functionalized calcium phosphate particles (Table 6).  
 
Table 6: Properties of calcium phosphate colloids from dynamic light 
scattering (DLS) and scanning electron microscopy (SEM). In all the cases, 
the concentrations of alkyl phosphates were 25 µM.  
Alkyl 
phosphates 
(25 µM) 
Particle size 
from DLS / nm 
PDI 
Zeta potential 
(standard 
deviation)  / mV 
Morphology; particle 
size by SEM / nm 
TDP 650 0.124 -33 (5) 
Flower-like particles; 
ca. 1000 
DDP 639 0.293 -22 (9) 
Needle-like particles;  
Length ca. 200-250 
and  width ca. 10-15 
ODP 993 0.378 -14 (4)
Flower-like particles; 
ca.1000 
DDOPhP 695 0.394 -22 (5)
DDOBPhP 1570 0.555 -6 (4)
 
In the case of DDP and DDOPhP, the colloids initially showed a particle 
size of about 600 to 700 nm in DLS, and then the particles aggregated 
slowly with time to microparticles. The colloids were stable for only three 
hours after that the particles were flocculated. In the cases of ODP and 
DDOBPhP, only the microparticles were observed in DLS and the colloids 
were flocculated from the solution after few minutes. 
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The unfunctionalized calcium phosphate particles had a slightly positive zeta 
potential of about +1.2 mV at a pH of 8.0.[18] In all cases, the adsorption of 
alkyl phosphates reduced the zeta potential to negative values, which 
indicates the adsorption of negatively charged alkyl phosphates on the 
calcium phosphate surface. The particles functionalized with the alkyl 
phosphates TDP, DDP and DDOPhP which are less hydrophobic show 
highly negative zeta potential values (-22…-33 mV). But the alkyl 
phosphates, ODP and DDOBPhP, which have either a long alkyl chain or a 
bulkier spacer group, show slightly negative zeta potential (-6...-14mV). The 
DLS data show that the alkyl phosphates which are less hydrophobic have a 
higher solubility in aqueous medium and have a higher affinity to bind with 
calcium ions. This stabilizes the particles for a few minutes.  
SEM pictures of the functionalized calcium phosphate particles with the 
addition of 25 µM of different types of alkyl phosphates (DDP, TDP, ODP, 
DDOPhP, and DDOBPhP) are shown in Figure 47. In the case of DDP, the 
SEM picture shows needle-like aggregated particles. The individual needle-
like particle has a length of 200 to 250 nm and a width of 10 to 15 nm. 
Unlike DDP, the SEM pictures of other alkyl phosphates-functionalized 
calcium phosphate particles show only flower-like particles with a size of 
about 1000 nm.  
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Figure 47: SEM picture of functionalized calcium phosphate particles with 
the addition of 25 µM of (a) DDP, (b) TDP, (c) ODP, (d) DDOPhP, and (e) 
DDOBPhP. 
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Figure 48: XRD data of alkyl phosphate-functionalized calcium phosphate 
particles. The width of the diffraction peaks of the functionalized calcium 
phosphate particles indicates a low crystallinity of the hydroxyapatite phase. 
The expected diffraction pattern for hydroxyapatite is shown at the bottom 
for comparison (black line). 
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The X-ray powder diffraction patterns of the five precipitates are shown in 
Figure 48. These X-ray data reveal that the precipitates produced by 
functionalization of the calcium phosphate nanoparticles with each of the 
five compounds, DDP, TDP, ODP, DDOPhP, and DDOBPhP, consist of 
poorly or moderately crystalline hydroxyapatite.  
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Figure 49: IR spectra of alkyl phosphate-functionalized calcium phosphate 
particles. The vertical dotted lines correspond to the bands of the alkyl 
phosphates. 
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Figure 49 shows the IR spectra of calcium phosphate particles functionalized 
with different types of alkyl phosphates (DDP, TDP, ODP, DDOPhP, and 
DDOBPhP). The ν4 PO43- bending mode at 550 cm-1 and the ν1, ν3 PO43- 
stretching mode at about 1000 cm-1 appeared in the IR spectra for all 
samples. The anisotropic local electrical field of the crystalline phase causes 
an absorption in the form of an apparent doublet (602 and 565 cm-1). The C-
H, C-C, and C=C-H stretching vibrations from alkyl phosphates were also 
observed at 2922, 2853, 1506, 1464 and 1385 cm-1 in the functionalized 
nanoparticles. Thus, the IR results confirmed the presence of alkyl 
phosphates and calcium phosphate. 
Table 7 shows the elemental analysis data of alkyl phosphate-functionalized 
calcium phosphate nanoparticles. The content of alkyl phosphate in the 
isolated particles was estimated as follows: The amount of alkyl phosphate 
used to functionalize the calcium phosphate particles was about 1-2 wt%. In 
the case of DDP, it was 1.1 wt%. If we assume that all the calcium and 
phosphate are present as hydroxyapatite, Ca5(PO4)3OH, elemental analysis 
of the DDP-functionalized particles by combustion elemental analysis gave 
about 10 wt% of DDP in the solid. About 9 wt% of excess amount of DDP 
was observed in the solid sample.  
In the same way, the excess amounts of alkyl phosphates were observed for 
all alkyl phosphate-functionalized the calcium phosphate particles.  
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Table 7: Elemental analysis data of alkyl phosphate-functionalized calcium phosphate particles, obtained by 
filtration and drying in air at 37 °C. CaP = calcium phosphate [Ca5(PO4)3OH]. 
25 µM of 
Alkyl 
phosphate1 
[Ca2+] / 
mM 
[PO43-] / 
mM 
C / % H / % Ca / % 
Inorganic 
phosphate, 
PO43- / % 
2Percentage 
of alkyl 
phosphate 
Composition 
TDP /  
1.21 wt% 
3 1.8 10.18 2.89 31.33 49.10 17.8 CaP + CaTDP + H2O 
DDP /  
1.10 wt% 
3 1.8 5.39 1.80 34.98 43.55 10.0 CaP + CaDDP + H2O 
ODP /  
1.43 wt% 
3 1.8 19.96 6.37 23.82 29.90 32.4 CaP + CaODP + H2O 
DDOPhP / 
1.46 wt% 
3 1.8 6.80 1.82 32.32 46.60 11.3 CaP + CaDDOPhP + H2O 
DDOBPhP / 
1.77 wt% 
3 1.8 6.94 1.68 33.21 42.23 10.5 CaP + CaDDOBPhP + H2O 
 
 
1Computed with respect to the amount of hydroxyapatite. It was assumed that all the calcium and phosphate 
precipitated as hydroxyapatite, Ca5(PO4)3OH. 
2Computed from the amount of carbon by the ratio of the molar masses of carbon and alkyl phosphate. 
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3.4.5. Conclusions 
We have prepared alkyl phosphate-functionalized calcium phosphate 
particles and characterized. About 1-2 wt% of alkyl phosphates were used to 
functionalize the calcium phosphate nanoparticles with respect to the amount 
of hydroxyapatite expected to be formed in colloids. The experimental 
results show that the alkyl phosphates have a very good attachment to the 
calcium phosphate surface.  
Although the surface charge of particles was negative, the presence of 
hydrophobic alkyl chains destabilized the dispersion of nanoparticles in the 
aqueous medium. The alkyl phosphates having less hydrophobic alkyl 
chains showed higher stability of the colloids for two to three hours, whereas 
the colloids prepared with alkyl phosphates which are highly hydrophobic, 
flocculated immediately. The length of the alkyl chain influenced the 
morphology of the calcium phosphate particles. SEM measurements showed 
needle-like particles in the case of DDP. Other alkyl phosphates showed 
only flower-like aggregated microparticles. The XRD data showed the poor 
crystallinity of the particles, and the presence of alkyl phosphates on the 
precipitated calcium phosphate particles was confirmed by the IR 
measurement.  
It was confirmed by elemental analysis that the content of alkyl phosphate in 
the precipitated particles were found to be in excess than used. It indicated 
that the alkyl phosphates adsorbed on the surface of calcium phosphate may 
have reacted and exchanged inorganic phosphates from the particles. As a 
result, the calcium salt of alkyl phosphates could be formed and precipitated 
with hydroxyapatite particles.  
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From the results it was concluded that the alkyl phosphates can have a high 
chemical affinity to bind with the calcium phosphate surface and form a 
hydrophobic layer on hydroxyapatite particles. Therefore, the particles 
aggregated in solution and precipitated. 
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4. Materials and methods 
4.1. Experimental procedures 
4.1.1 Used chemicals  
Chemical name Chemical company 
5,10,15,20-tetrakis(4-hydroxyphenyl)porphine Aldrich 
1H-tetrazole (≈ 0.45 M in CH3CN) Fluka 
m-chloroperbenzoic acid (Assay 70%) Aldrich 
Dodecasodium salt of phytic acid Aldrich 
L-tyrosine Fluka 
Phosphorus oxychloride Riedel-de Haen 
Orthophosphoric acid (85%) Acros organics 
Phosphorus pentoxide Riedel-de Haen 
Phosphorus trichloride Fluka 
N,N-diethylamine Merck 
Triethylamine Fluka 
Pyridine Bernd Kraft GMBH 
Hexamethyldisiloxane Fluka
1-butanol Merck 
1-doceanol Aldrich 
1-tetradecanol ABCR
1-octadecanol ABCR 
Hydroquinone Riedel-de Haen 
4,4’-dihydroxybiphenyl Fluka 
1-dodecyl bromide Aldrich 
CDCl3 Aldrich 
D2O Aldrich 
 
The chemicals mentioned above were used without further purification. All 
the experiments were performed under nitrogen atmosphere in oven-dried 
glassware following the standard schlenk techniques. Solvents used as 
reaction media were distilled immediately before use. Benzene, diethylether, 
n-hexane and 1,4-dioxane were dried over sodium/benzophenone. N,N-
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diethylformamide was dried over activated molecular sieves. 
Dichloromethane was dried over calcium hydride. Pyridine, N,N-
diethylamine and triethylamine were dried over KOH. Ethanol and methanol 
were reagent grade solvents.  
  
4.1.2. Preparation of N,N-diethylphosphoramidous dichloride 
The compound was prepared according to the procedure.[219] Diethylamine 
(73 g, 1 mmol) in dry diethyl ether (100 ml) was added drop wise to a 
vigorously stirred solution of PCl3 (68.75 g, 0.5 mmol) in dry diethyl ether 
(250 ml). The reaction temperature was kept below 0 °C (liquid 
nitrogen/acetone). On completion of addition, the mixture was stirred for 3 
hours at room temperature. The mixture was then filtered through G4 frit 
and washed with 100 ml of dry ether. Evapouration of the combined diethyl 
ether solutions under reduced pressure followed by distillation of the crude 
liquid residual under vacuum gave a clear liquid. The yield was 76.5 g (87.5 
%). 
31P-NMR (CDCl3): δ = 170 ppm (s). 
 
4.1.3. Preparation of di-tert-butyl-N,N-diethylphosphoramidite 
The compound was prepared according to the procedure.[219] A solution of 
tert-butanol (0.88 mmol) and triethylamine (0.88 mmol) in dry ether (160 
ml) was added to N,N-diethylphosphoramidous dichloride (76.5 g, 0.44 
mmol) in dry ether (100 ml). The reaction mixture was kept below 0 °C 
(liquid nitrogen/acetone). On completion of addition, the mixture was stirred 
at room temperature for 3 hours. A solution of 5 % aqueous solution of 
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NaHCO3 (70 ml) was then added, the mixture transferred to a separating 
funnel, and the aqueous phase discarded. The ethereal phase was washed 
with 5 % aqueous solution of NaHCO3 (2·60 ml), saturated aqueous solution 
of NaCl (60 ml), and dried over Na2SO4. Filtration and evapouration of the 
solvent under reduced pressure followed by distillation of the crude residual 
under vacuum gave a clear liquid. The yield was (60 %). The product was 
used for phosphorylation step without further purification. 
31P-NMR (CDCl3): δ = 134.4 ppm (s). Impurities: 8.4 ppm (s, 5.6 %); -2.48 
ppm (s, 1.4 %). 1H-NMR (CDCl3): δ = 0.92 ppm (t, -CH3, J = 7.16 Hz, 6H); 
1.2 ppm (s, (-C(CH3)3), 18 H,); 2.9 ppm (doublet of quartet, -CH2, J = 7.16 
Hz, 4H). 13C-NMR (CDCl3): δ = 15.6 ppm (d, J = 5.1 Hz); 31.7 ppm (d, J = 
8.7 Hz); 38.2 ppm (d, J = 21.8 Hz); 75.14 ppm (d, J = 10.9 Hz). 
 
4.1.4. Synthesis of 5,10,15,20-tetrakis(4-phosphonoxyphenyl)porphine 
(p-TPPP) 
4.1.4.1. Phosphorylation of p-THPP 
1H-Tetrazole in acetonitril (4.2 ml, 3.3134 g, 47.3 mmol) was added in one 
portion to a stirred solution of the p-THPP [5,10,15,20-tetrakis(4-
hydroxyphenyl)porphine] (0.2007 g, 0.296 mmol) and di-tert-butyl-N,N-
diethylphosphoramidite (1.1796 g, 1.3 ml, 4.73 mmol) in dry 
dimethylformamide (20 ml) and stirred for 16 hours at room temperature. 
The mixture was then cooled to -40 °C (acetone/liquid nitrogen), and a 
solution of MCPBA   (70 % of m-chloroperbenzoic acid from ALDRICH) 
(2.3351 g, 9.47 mmol) in CH2Cl2 (30 ml) was rapidly added so that the 
reaction temperature was kept below 0 °C. After stirring for 1 hour at 0 °C,   
10 % aqueous Na2S2O5 (50 ml) was added and the mixture was stirred for 
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another 15 minutes. The product was extracted with CH2Cl2 (200 ml). The 
organic phase was washed with 10 % aqueous Na2S2O5 (2·50 ml), 0.5 M 
aqueous NaOH (2·50ml), dried over Na2SO4 and filtered. The solution was 
concentrated to 5 ml under vacuum, mixed with 100 ml of n-hexane and 
cooled overnight to 4 °C. The precipitated brown residue was washed three 
times with n-hexane and dried under vacuum. The yield was 356 mg (83 %). 
31P-NMR (CDCl3): δ = -14.58 ppm (s). 1H-NMR (CDCl3): δ = -2.84 ppm (br 
s, 2 H, NH) 1.69 ppm (s, 72 H, CH3); 7.62 ppm (d, J = 8.48 Hz, 8 H, Ar); 
8.15 ppm (d, J = 8.48 Hz, 8 H, Ar); 8.85 ppm (s, 8 H, pyrrole). 13C-NMR 
(CDCl3): δ = 30.16 ppm (d, J = 4.36 Hz, CH3); 84.15 ppm (d, J = 7.27 Hz, t-
butyl C-O); 118.51 ppm (d, J = 5.09 Hz, Ar-ortho C); 119.49 ppm (pyrrole); 
135.5 ppm (Ar-para C); 138.32 ppm (Ar-meta C); 151.64 ppm (d, J = 7.27 
Hz, Ar-ipso C).  
 
4.1.4.2. Deprotection 
20 ml of concentrated HCl was added to 356 mg of the above compound in 
80 ml of dry dioxane. The solution turned green. The mixture was stirred for 
three hours and removal of the solvent under vacuum gave a green solid 
which was dried in a desiccator. The yield was 253 mg (95%). The sodium 
salt of p-TPPP was prepared by adding 10 equivalents of sodium ethoxide 
dissolved in 150 ml dry ethanol. The resulting brown precipitate was stirred 
for 3 hours, filtered off under nitrogen atmosphere, washed several times 
with dry ethanol and dried in vacuum. The compound was highly 
hygroscopic. The hydration of the substance was clearly visible by the color 
change from brown to green. UV-visible measurement in water: λmax at pH 
10 (log ε) = 416 nm (5.57); λmax at pH 5 (log ε) = 438 nm (5.57). IR (KBr) 
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cm-1: 1638, 1603, 1504, 1467, 1400, 1385 (aromatic C=C, C=N ring stretch), 
1240 (C-O stretch), 1172, 1107 (PO42-), 982 (C-O-P), 890, 804, 732 (C=C-H 
out of plane bend), 642, 575 (PO42-). 31P-NMR (D2O): δ = 1.1 ppm (s). 1H-
NMR (D2O): δ = 7.52 ppm (d, 8 H, J = 8.48 Hz, Ar); 8.04 ppm (d, 8 H, J = 
8.48 Hz, Ar); 9.03 ppm (br s, 8 H, Pyr). 13C-NMR (D2O): 119.6 ppm (d, J = 
3.63 Hz, Ar-ortho C), 120.3 ppm, 135.6 ppm (Ar-para C), 136.8 ppm (Ar-
meta C), 154.7 ppm (d, J = 5.81 Hz, Ar-ipso C). ESI-MS- m/z = 248.5158 
(M4-), C44H30N4O16P44- would be 248.5157.   
 
4.1.5. Preparation of O-phospho-L-tyrosine 
The compound was prepared according to the procedure.[242] In a 100 ml 
round bottom schlenk flask equipped with a magnetic stirrer, fresh 
phosphorus pentoxide (10 g, 70.4 mmol) and 85 % phosphorus acid in water 
(12 ml) are placed. L-tyrosine (3.22 g, 17.8 mmol) was added and mixed 
with the aid of a vibramix. The reaction mixture is heated and stirred at 80 
°C for 40 hours. To the amber viscous liquid, water (30 ml) was added and 
heating was continued for 30 minutes. The reaction mixture was cooled to 
room temperature, diluted with n-butanol (650 ml) and kept stirring for 3 
hours. The fine white precipitate was filtered washed successively with ice 
water (2·20 ml), ethanol (2·20 ml) and ether (4·20 ml). The yield was 2.42 g 
(50 %). 
IR (KBr) cm-1: 3310-3600 cm-1 (broad band, O-H and N-H stretch), 3123, 
3086, and 3024 (aromatic C-H stretch), 2976 and 2926 cm-1 (aliphatic C-H 
stretch), 1732 cm-1 (carboxylic C=O stretch), 1607, 1512, 1456, 1385, 1230, 
1144, 1045, 953 (C=C, C-N, N-H, PO42-) 851 (C-H out of plane bend), 561, 
571 (PO42-). 31P-NMR (D2O): δ = -3.27 ppm (s). 1H-NMR (D2O): δ =2.94 to 
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3.19 ppm (doublet of quartet, -CH2-Ar; 2H); 4.05 to 4.09 ppm (doublet of 
doublet, chiral-CH, 1H); 6.98 to 7.12 ppm (doublet of doublet, Ar, 4H). 13C-
NMR (D2O): δ = 35.2 ppm (-CH2-); 54.6 ppm (-CH-); 121.36 ppm (d, o-C); 
130.07 ppm (p-C); 130.08 ppm (m-C); 151.9 ppm (d, ipso-C); 172.04 ppm (-
C(O)-O). Elemental Analysis: calculated for (C9H12N1O6P1): C, 41.39; H, 
4.63; N, 5.36. Found: 41.05; H, 4.695; N, 5.27. ESI-MS+ m/z = 306.0103 
(M+), C9H11N1Na2O6P1+ would be 306.0114.  
 
4.1.6. Dodecyl phosphate (DDP) 
The compound was prepared according to the procedure.[243] In a dry, 
nitrogen purged flask, equipped with a reflux condenser, a magnetic stirrer, 
and a dropping funnel was placed 8.2 g (57.9 mmol) of diphosphorus 
pentoxide. Toluene (100 ml) and 18.81 g (24.6 ml, 115.8 mmol) of 
hexamethyldisiloxane were added. The mixture was refluxed, until it became 
clear (ca. 1h). After cooling, 21.58 g (25.9 ml, 115.8 mmol) of 1-dodecanol 
was added drop wise, and it was refluxed for 3 h. The solution was cooled 
and removal of solvent in vacuo left viscous oily residue. The residue was 
dissolved in 120 ml of ether. The ethereal solution was washed twice with 
10 ml of water and, subsequently extracted three times with 20 ml of 5% 
sodium hydroxide solution. The combined alkaline extracts were acidified 
with 60 ml of 10% hydrochloric acid solution, and again extracted three 
times with 100 ml of ether. The ethereal solution was dried (Na2SO4), and 
evaporation of the ether gave 13.25 g of colorless crystalline product (43 % 
yield) in an almost pure state. The product was recrystallized in n-hexane. 
m. p: 59.1 °C to 60.3 °C. 31P-NMR (CDCl3): δ = 2.29 ppm (s). 1H- NMR 
(CDCl3): δ = 0.86 ppm (t, -CH3); 1.24 ppm (s, -(CH2)9-); 1.65 ppm (quintet, 
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-CH2-); 4.01 ppm (quartet, -CH2-O-). Elemental analysis. Calculated for 
(C12H27O4P1): C, 54.12; H, 10.22. Found: C, 54.14; H, 10.44.  
The sodium salt of dodecyl phosphoric acid was prepared by treating the 
free acid with two equivalents of sodium ethoxide in hot ethanol. The 
immediately formed white solid was allowed to stir for 3 h at room 
temperature. The solid was collected by filtration and vacuum dried under 
vacuum.  
31P-NMR (D2O): δ = 4.34 ppm (s). 1H-NMR (D2O): δ = 0.69 ppm (t, -CH3); 
1.11 ppm (s, -(CH2)7-); 1.39 ppm (quintet, -CH2-); 3.56 ppm (quartet, -CH2-
O-). Elemental analysis: Calculated for (C12H25O4P1Na2): C, 46.45; H, 8.12; 
Na, 14.82. Found: C, 46.75; H, 8.575; Na, 14.46.  
 
4.1.7. Tetradecyl phosphate (TDP) 
The preparation of TDP was carried out as described above for DDP. The 
yield was 44 %.  
31P-NMR (CDCl3): δ = 2.96 ppm (s). 1H-NMR (CDCl3): δ = 0.82 ppm (t, -
CH3); 1.27 ppm (s, -(CH2)9-); 1.67 ppm (quintet, -CH2-); 4.02 ppm (quartet, 
-CH2-O-); 8.7 ppm (s,-OH). Elemental analysis: Calculated for 
(C14H31O4P1): C, 57.12; H, 10.61. Found: C, 57.5; H, 10.93.  
The sodium salt of tetradecyl phosphoric acid was prepared by treating the 
free acid with 2 equivalents of sodium ethoxide in hot ethanol. The 
immediately formed white solid was allowed to stir for 3 h at room 
temperature. The solid was collected by filtration and dried under vacuum.  
31P NMR (CDCl3): δ = 4.30 ppm (s). 1H-NMR (CDCl3): δ = 0.69 ppm (t, -
CH3); 1.11 ppm (s, -(CH2)7-); 1.40 ppm (quintet, -CH2-); 3.56 ppm (quartet, 
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-CH2-O-). Elemental analysis: Calculated for (C14H29O4P1Na2): C, 49.70; H, 
8.64; Na, 13.59. Found: C, 50.57; H, 8.95; Na, 13.7. 
 
4.1.8. Octadecyl phosphate (ODP) 
The preparation of ODP was carried out as described above for DDP. The 
yield was 35 %. 31P-NMR (CDCl3/DMSO–d6): δ = –0.5 ppm (s). 1H-NMR 
(CDCl3/DMSO–d6): δ = 0.84 ppm (t, -CH3); 1.22 ppm (s, -(CH2)9-); 1.55 
ppm (quintet, -CH2-); 3.80 ppm (quartet, -CH2-O-). Elemental analysis: 
Calculated for (C18H39O4P1): C, 61.69; H, 11.2. Found: C, 61.57; H, 11.57. 
The potassium salt of octadecyl phosphoric acid was prepared by treating the 
free acid with potassium ethoxide in hot ethanol. The immediately formed 
white solid was allowed to stir for 3 h at room temperature. The solid was 
collected by filtration and dried under vacuum. Elemental analysis: 
Calculated for (C18H39O4P1): C, 50.67; H, 8.74. Found: C, 50.043; H, 9.25. 
 
4.1.9. p-dodecyloxyphenyl phosphate (DDOPhP) 
4.1.9.1. p-dodecyloxyphenol 
A mixture of hydroquinone (59.4 g, 0.54 mol), dodecylbromide (34.8923 g, 
0.14 mol), K2CO3 (37.25 g, 0.27 mol) and cyclohexanone (150 ml) was 
refluxed for 24 h. The solvent was removed and the residue was redissolved 
in CH2Cl2 and aqueous HCl mixture. The acid layer was extracted several 
times with CH2Cl2 and the combined layer was washed two times with 
water. The organic layer was dried over Na2SO4 and the solvent was 
evaporated in rotary evaporator.  Recrystallizing the product from ethanol at 
room temperature separated the mixture of the product.  
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1H-NMR (DMSO-d6): δ = 0.88 ppm (t, CH3, 3H); 1.25 to 1.5 ppm (18 H); 
1.75 ppm (quintet, CH2, 2H); 3.89 ppm (t, α-CH2, 2H); 6.7 to 6.81 ppm (m, 
Ar, 4H). 13C-NMR (DMSO-d6): δ = 153.45 ppm; 149.37 ppm; 116.08 ppm; 
115.7 ppm; 68.82 ppm; 32.04 ppm; 29.77 ppm; 29.53 ppm; 29.49 ppm; 
29.46 ppm; 26.15 ppm; 22.80 ppm; 14.23 ppm. 
 
4.1.9.2. p-dodecyloxyphenyl phosphate 
2 g of p-dodecyloxyphenol (7.18 mmol, 1 equivalent) was taken in 80 ml of 
Benzene. To the clear solution, 6.575 ml of POCl3 (11.0139 g, 71.8 mol, 10 
equivalents) was added. The clear solution was refluxed for 18 hours. The 
mixture was cooled to room temperature and removal of the solvent under 
vacuo left white residue. It was taken in 100 ml of ether and 20 ml of water 
was added to it under cold condition. The mixture was stirred overnight at 
room temperature. The ether layer was separated, washed with 10 ml of 
water and dried over Na2SO4. The solvent was removed under vacuum. The 
product was recrystallized several times from hot n-hexane. The yield was 
very poor (10 %). The experiment was carried out in the presence of base, 
pyridine or triethylamine, improved the yield (30 %). 
31P-NMR (DMSO-d6): δ = -4.67 ppm (s). 1H-NMR (DMSO-d6): δ = 0.85 
ppm (t, CH3, 3H); 1.24 – 1.37 ppm (18 H); 1.67 ppm (quintet, CH2, 2H); 
3.89 ppm (t, α-CH2, 2H); 6.7 to 7.06 ppm (m, Ar, 4H). 13C-NMR (DMSO-
d6): δ = 155.035 ppm; 144.91 ppm (d); 121.01 ppm (d); 115.28 ppm, 67.1 
ppm, 31.31 ppm, 29.03 ppm, 28.79 ppm, 28.73 ppm, 25.53 ppm, 22.11 ppm, 
13.96 ppm. Elemental Analysis: Calculated for (C18H31O5P1): C, 60.32; H, 
8.72. Found: C, 60.52; H, 9.015. 
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4.1.10. p-dodecyloxybiphenyl-p'-phosphate (DDOBPhP) 
4.1.10.1. p-dodecyloxy-p'-hydroxybiphenyl 
A schlenk flask equipped with a magnetic stirrer, 18.621 g of 4,4’-
dihydroxybiphenyl (100 mmol), 1.3336 g of NaOH (33 mmol) and 8.077 g 
of 1-bromododecane (8 ml, 33 mmol) in 400 ml of absolute Ethanol was 
refluxed at 80 °C for 4 hours. The mixture was allowed to stand overnight at 
room temperature. The crystallized solid was filtered and washed with 
minimum amount of ethanol. The solid was dried overnight under vacuum. 
The yield was 6.44 g (55 %).  
1H-NMR (CDCl3/DMSO-d6): δ = 0.73 ppm (t, CH3, 3H); 1.12 to 1.32 ppm 
(γ-CH2 and (CH2)8, 18 H); 1.63 ppm (quintet, β-CH2, 2H); 3.8 ppm (t, α-
CH2, 2H); 6.7 ppm (4peaks grouped, 3,3’-H of biphenyl, 4H); 7.24 ppm (4 
peaks grouped, 2,2’-H of biphenyl, 4H); 8.89 ppm (br s, -OH, 1H). 13C-
NMR (CDCl3/DMSO-d6): δ = 157.09 ppm (s, 4-C of biphenyl); 155.74 ppm 
(s, 4’-C of biphenyl); 132.4 ppm (s, 1-C of biphenyl); 130.8 ppm (s, 1’-C of 
biphenyl); 126.6 ppm (s, 2’-C of biphenyl); 126.4 ppm (s, 2-C of biphenyl); 
114.9 ppm (s, 3’-C of biphenyl); 113.9 ppm (s, 3-C of biphenyl); 67.1 ppm 
(s, 1-C of alkyl chain); 30.9 ppm (10-C); 28.68 ppm, 28.66 ppm, 28.63 ppm, 
28.44 ppm, 28.37 ppm (2,4,9-C); 25.13 ppm (3-C); 21.74 ppm (11-C); 13.35 
ppm (12-C). Elemental analysis: Caculated for (C24H34O2): C, 81.31; H, 
9.67. Found: C, 81.63; H, 10.09. 
 
4.1.10.2. p-dodecyloxybiphenyl-p'-phosphate 
To the freshly prepared p-dodecyloxy-p-hydroxybiphenyl (5 g, 14.1 mmol) 
in dry benzene (80 ml), POCl3 (141 mmol) was added and warmed the 
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solution to 50 °C. 1.6733 g of pyridine (141 mmol) was slowly added drop 
wise. The solution was refluxed for 3.5 hours. After cooling, the mixture 
was filtered and the solvent was evapourated under vacuum. The residue 
was treated with 25 ml of water and stirred overnight. To this 100 ml of dry 
ethanol was added and warmed to 100 °C. The milky white precipitate was 
immediately filtered and dried under vacuum. The yield was 22 %. 
31P-NMR (DMSO-d6): δ = -4.66 ppm (s). 1H-NMR (DMSO-d6): δ = 0.85 
ppm (t, J = 6.97 Hz, CH3, 3H); 1.36 ppm ( γ-CH2 and (CH2)8, 18 H); 1.71 
ppm (quintet, J = 6.41 Hz, β-CH2, 2H); 3.9 ppm (t, J = 6.41 Hz, α-CH2, 2H); 
6.95 ppm (d, J = 8.67 Hz, 4H); 7.20 ppm (d, J = 8.67 Hz, 2H); 7.51 ppm (dd, 
J = 6.78 Hz, 4H). 13C-NMR (DMSO-d6): δ = 158.16 ppm; 150.55 ppm; 
135.69 ppm; 131.77 ppm; 127.5 ppm; 127.2 ppm; 120.46 (d, J = 5.1 Hz); 
114.83 ppm; 67.5 ppm; 31.31 ppm; 29.05 ppm, 29.02 ppm, 28.77 ppm, 
28.68 ppm (m); 25.52 ppm; 22.11 ppm; 13.97 ppm. Elemental analysis: 
Caculated for (C24H35O5P1): C, 66.34; H, 8.12. Found: C, 66.56; H, 8.21. 
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4.1.11. Preparation of organic phosphate-functionalized calcium 
phosphate nanoparticles: General procedure 
 
 
Figure 50:  Schematic diagram of the preparation of functionalized calcium 
phosphate nanoparticles. 
 
The calcium phosphate nanoparticles were prepared by pumping aqueous 
solutions of Ca(NO3)2·4 H2O and (NH4)2HPO4 into a stirred vessel (see Fig. 
50). The concentration of calcium and phosphate solutions was used with the 
stoichiometric ratio (Ca:P = 1.67:1), corresponding to hydroxyapatite 
[Ca5(PO4)3(OH)]. The pH of the calcium and phosphate solutions was 
previously adjusted to 9-10 with 0.1 N aqueous NaOH. A few seconds after 
mixing, the nanoparticle dispersion was taken with a syringe. The colloids 
were prepared by rapidly mixing an aqueous solution of the organic 
phosphate and the dispersed calcium phosphate nanoparticles. The final pH 
of the colloid was between 7.5 and 8.5. The particles were studied either as 
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dispersion or after collecting the particles by ultracentrifugation at 371,000 g 
or by filtration (supra®-100 by PALL Life sciences). The centrifuged or 
filtered nanoparticles were washed with 100 ml of absolute ethanol and dried 
in air. Ultrapure water (Purelab ultra instrument from ELGA) was used for 
all preparations. 
 
4.1.12. Cell culture experiments 
In the cooperation with the University of Bochum, Chair of Molecular 
Neurochemistry, the cell culture studies were carried out. All cell culture 
work was carried out with sterile solutions. NIH 3T3 cells (fibroblasts) were 
used. The cells were seeded 24 h before the experiment in 24-well plates 
with 50,000 cells per well. 100 µl of the calcium phosphate/p-TPPP colloid 
with a p-TPPP concentration of 7.5 µM were mixed with 500 µl cell culture 
medium (RPMI-1640 with 10 % FCS). The cell culture medium was 
removed and replaced with 500 µl of the above described mixture. Before 
the microscopic analysis, the cells were washed twice with PBS to remove 
dispersed particles and dissolved porphyrin. Fluorescence microscopy was 
carried out with an IX51 microscope (Olympus, Hamburg, Germany) and a 
Leica TCF SP2 confocal laser scanning microscope.  
An MTT-assay was performed as follows: The MTT stock solution, 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide in PBS (5 mg ml-1) 
was prepared and diluted to 1 mg ml-1 in cell culture medium. The cells were 
seeded for 24 h before the incubation with calcium phosphate/p-TPPP-
nanoparticles. After 7, 24 and 48 h incubation, respectively, the cell culture 
medium was replaced with 300 µl of the MTT solution and the cells were 
incubated for 1 h at 37 °C under 5 % CO2. Then the MTT solution was 
 115
removed and replaced with 300 µl DMSO solution. The cells were incubated 
for 30 more minutes under the conditions described above and then a 70 µl 
aliquot was taken for spectrophotometric analysis using a ELISA-Reader 
(SLT Labinstruments, Salzburg, Austria) operating at λ = 560-600 nm.  
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4.2. Instrumental techniques 
4.2.1. Nuclear magnetic resonance (NMR) 
Nuclear magnetic resonance spectroscopy is another form of absorption 
spectroscopy. It is concerned with the nuclear spin in the lowest energy 
state. A sample can absorb electromagnetic radiation in the radio frequency 
region at frequencies specially governed by the characteristics of the sample. 
The fundamental relationship in NMR is the Larmor equation. 
ν = γ · Bo/2π 
where 
γ = 2πµ/hI 
This equation correlates the applied radio frequency (ν) with the magnetic 
field strength (B0). The magnetogyric ratio (γ) is the proportionality constant 
between the magnetic moment (μ) and the spin number (I). Generally the 
resonance frequencies are expressed relative to a standard compound. 
Tetramethylsilane (TMS) is the standard for both 1H and 13C NMR. The 
difference in the absorption position of a particular proton from the 
absorption position of a reference proton is called the chemical shift of this 
particular proton.  
 
 
The chemical shifts of the NMR signals were determined in parts per million 
(ppm) and are referenced to residual solvent peaks (1H- and 13C NMR). The 
samples for 31P-NMR were referenced externally with 85 % H3PO4.  
 
Chemical shift from Reference in Hz 
 
Spectrometer Frequency in Hz 
Chemical Shift in ppm (δ) = · 106
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1H-, 13C-, and 31P-NMR measurements were carried out with a Bruker DPX 
300 MHz NMR spectrometer operating at 300 MHz, 75.5 MHz, and 121.5 
MHz respectively. Standard NMR tubes with a diameter of 5 mm were used. 
About 10 to 15 mg of a sample were dissolved in 0.5 to 0.6 ml of the 
deuterated solvent.  
 
4.2.2 Dynamic light scattering (DLS) 
Dynamic light scattering is one of the methods used to determine the size of 
particles. The experiment’s theory is based essentially on two assumptions. 
The first assumption is that the particles are in Brownian motion. The second 
one is that the particles observed in the experiment are spherical with a 
diameter that is small compared to the molecular dimensions.  
Shining a monochromatic light beam onto a solution with spherical particles 
in Brownian motion causes a Doppler shift when the light hits the moving 
particle, changing the wavelength of the incoming light. This change is 
related to the size of the particle. It is possible to compute the sphere size 
distribution and give a description of the particle’s motion in the medium, 
measuring the diffusion coefficient of the particle: 
 
DT = kB T / 6 π ηRh 
 
where DT  is the translation diffusion coefficient, kB is the Boltzmann's 
constant, T is the temperature in Kelvin degrees, η is the viscosity of the 
solvent and Rh is the hydrodynamic radius. Since from the light scattering it 
is possible to obtain information about the positions of the particles, from the 
formulas above the radius of the particles can be computed. 
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Dynamic light scattering determinations were performed with a Zetasizer 
(NanoZS from Malvern instruments). 
4.2.3 Zeta potential measurements (ZP) 
The zeta potential is the electrical potential that exists at the Stern plane of a 
particle, which is at some small distance from its surface. The zeta potential 
is derived from measuring the mobility distribution of a dispersion of 
charged particles as they are subjected to an electric field. The particle 
mobility is defined as the velocity of a particle per electric field unit and is 
measured by applying an electric field to the dispersion of particles and 
measuring their average velocity. There are two approximations (by Hückel 
and by Smoluchowski) to obtain the zeta potential from the measured 
particle mobility. The approximation by Hückel applies to particles smaller 
than 10 nm. Because our particles were larger the model of Smoluchowski 
was used.  
Be = (ε ζ ƒb / η) (ω r2T ρ / η) 
 
Be: electrophoretic mobility, ε: dielectric constant, ζ: zeta potential, η: 
viscosity, ω: frequency of the electrical field, r: radius of the particle, ρ: 
density of the dispersion, ƒb: correction factor. 
The measurements for the computation of the zeta potential were carried out 
with a Malvern Zetasizer Nano ZS. 
4.2.4 Infrared spectroscopy (IR) 
Infrared spectroscopy (IR Spectroscopy) is a type of absorption spectroscopy 
that uses the infrared part of the electromagnetic spectrum (wavelength 760 
nm up to 500 µm). Infrared radiation does not trigger electronic excitation in 
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substances but vibrational and/or rotational excitation. To be infrared active, 
a molecule must possess a dipole moment or must generate a dipole moment 
by vibration. The main modes of vibration are valence bond vibration, in 
which the atom vibrates along a bond axis, and deformation vibration, which 
occurs in molecules (bending/rocking vibrations - in the plane of the bonds 
or twisting/wagging vibrations - out of the plane of the bands). The energy 
in infrared spectra is usually given in wave numbers. The use of wave 
numbers offers the advantage of being directly proportional to the frequency 
of the absorbed radiation and thus the energy absorbed.  Infrared 
spectroscopy deals with the interaction of infrared light with matter. The 
energy of an infrared photon can be calculated using the Planck energy 
relation 
 
with E  the  absorbed  energy  in J,  h = 6.626·10-34  J s Planck’s constant, c = 
3·1010 cm s-1 the speed of light, and ν  the wave number in cm-1. 
  
The extent of absorption of infrared photons depends mainly on the mass of 
the vibrating atoms. Detailed information about the infrared absorptions 
observed for various functional groups can be found in the literature. 
All the samples examined were mixed with an about 200 fold excess of 
potassium bromide and pressed into pellets at 10 tons for 15 minutes. 
Measurements were carried out with a Bruker Vertex 70 FT-IR spectrometer 
(resolution 2 cm-1, averaging of 20 scans) 
 
ΔE = h c ν
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4.2.5 X-ray diffractometry (XRD) 
Crystals are ordered, three-dimensional arrangements of atoms with 
characteristic periodicities.  As the spacing between atoms is of the same 
order as X-ray wavelengths (1-3 Å), crystals can diffract the radiation when 
the diffracted beams are inphase.  The Bragg equation is given as  
 
n · λ = 2 · dhkl · sin(θ) 
 
For a given wavelength (λ), diffraction can only occur at a certain angle (θ) 
for a given d-spacing between the lattice planes hkl in Å. Here n is an 
integer value.  
X-rays can be used to measure the distance between successive atomic 
planes and positions of atoms or ions within a crystal, allowing for the 
determination of crystal structure, whereas powder XRD can be used to 
fingerprint minerals without any prior knowledge of crystal structure or 
symmetry. 
X-ray powder diffraction was measured in the instrument: STOE IP-PSD 
diffractometer or Siemens D500 diffractometer. The samples were measured 
with Cu Kα1-radiation (λ = 1.54056 Ǻ), with 50 kV and 30 mA.  
 
4.2.6 Scanning electron microscopy (SEM) 
Classical microscopes are limited in resolution to the wavelength of visible 
light (400-750 nm). The scanning electron microscope (SEM) is a type of 
electron microscope capable of producing high-resolution images of a 
sample surface. With scanning electron microscopes, much smaller objects 
can be observed because high energy electrons are used for image creation. 
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When an electron beam interacts with a solid, various types of elastic and 
inelastic processes occur, including electron scattering and excitation. The 
inelastic scattering of secondary electrons is detected here. The secondary 
electron current reaching the detector is recorded and the microscope image 
consists of a plot of this current against probe position on the surface. The 
contrast in micrograph arises from variations in the surface topography. 
Consequently, the scanning electron microscopy provides a direct image of 
the topographical nature of the surface from all the excited secondary 
electrons. 
The samples must be sputtered with a thin film of gold-palladium [80:20], so 
that the samples must be electrically conducting. This thin metal coating 
does not affect the surface features of the sample. This type of coating is 
essential for insulators.  Sputtering exposes the samples to seven minutes of 
vacuum and an electric field.  
For the SEM observation, a FEI ESEM Quanta 400 FEG microscope 
coupled with energy-dispersive X-ray spectroscopy (SEM-EDX) was used. 
The analysis of elements present in the sample was detected by EDX with a 
the S-UTW-Si(Li) detector. 
 
4.2.7. UV-vis spectroscopy 
UV-vis spectroscopy refers to electronic transitions occurring in the region 
of the electromagnetic spectrum (200-800 nm) accessible to standard UV-vis 
spectrometers. When sample molecules are exposed to light having an 
energy that matches a possible electronic transition within the molecule, 
some of the light energy will be absorbed as the electron is promoted to a 
higher energy orbital. An optical spectrometer records the wavelengths at 
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which absorption occurs, together with the degree of absorption at each 
wavelength. The resulting spectrum is presented as a graph of absorbance 
(A) versus wavelength. Beer-Lambert’s Law is given as 
 
A = ε · c · l 
 
where ε is the absorption coefficient (dm3 mol-1 cm-1) of the absorbing 
medium, c is the concentration (mol dm-3) of the sample and l is the path 
length  (cm) through the sample. According to Beer-Lambert’s law, 
absorption is directly proportional to concentration and the path length. The 
unknown concentrations of the sample can be measured by plotting the 
absorption (A) versus known concentration (c) of the standard samples. This 
results in a linear plot, obeying the Beer-Lambert’s law.  
The spectral lines are normally broad due to the collision of the molecules in 
the liquid phase. This is often referred as collision broadening.  
It is most commonly used to refer the shifts in absorption bands and their 
intensity changes as follows: 
Bathochromic shift or red shift: a shift of λmax to longer wavelengths. 
Hypsochromc shift or blue shift: a shift of λmax to shorter wavelengths. 
Hyperchromic shift: an increase in the intensity of an absorption band, 
usually with reference to its molar extinction coefficient εmax. 
Hypochromic shift: a decrease in the intensity of an absorption band with 
reference to εmax.  
Varian Cary WinUV spectrophotometer was used and the samples were 
loaded in 1 cm quartz cuvettes.  A blank sample was measured first by 
placing the empty cuvette by which the instrument has been zeroed by 
displaying an absorbance value of 0.0000. The absorbance value may vary 
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slightly (about ± 0.0005). This may be due to noise. After this measurement, 
the solvent (normally water) was measured as background. The samples 
were measured further using the same cuvette. 
  
4.2.8. Fluorescence spectroscopy 
Fluorescence occurs when a molecule absorbs photons from the UV-vis light 
spectrum (200-900 nm), causing transition to a high-energy electronic 
singlet state and then emits photons as it returns to its initial state, in less 
than 10-9 sec. The absorbed photon must be equivalent to the energy 
difference between the ground state and the higher energy state. This energy 
is termed the excitation energy and the corresponding wavelength is called 
the excitation wavelength. The emission energy from the excited molecule to 
the ground state through heat and/or emission of energy quanta such as 
photons is also equivalent to the difference between the two discrete energy 
levels. This is referred to as emission energy and the corresponding 
wavelength is called emission wavelength. Some energy within the molecule 
is lost through heat or vibration so that the emitted energy is less than the 
excitation energy; therefore, the emission wavelength is always longer than 
the excitation wavelength. The difference between the excitation and 
emission wavelengths is called the Stokes shift.  
Emission and excitation spectra were measured at room temperature using a 
J&M spectrofluorometer (Analytische Mess- und Regeltechnik FL3095-500) 
equipped with a diode array polychromator and a 75 W Xenon lamp. The 
emission spectra were corrected for the detector sensitivity and the 
excitation spectra for the intensity of the exciting light. 
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4.2.9. Electron spray ionization mass spectrometry 
Bruker BioTOF III electron spray ionization-mass spectrometry equipped 
with an electron spray ionisation gun was employed to measure the 
molecular weight of the sample. Ultrapure water was used to prepare the 
samples and the concentration of the samples was up to 10 µM.  
The samples were measured in the Institute of Organic Chemistry, 
University of Duisburg-Essen. 
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5. Summary 
The principal goals of this thesis were to functionalize calcium phosphate 
nanoparticles with organic phosphates and to stabilize the nanoparticles as 
stable colloid. The intention of this project was approached successfully with 
some organic phosphates. The results are summarized here.  
The calcium phosphate nanoparticles were prepared by a continuous 
precipitation method and immediately stabilized as colloid by rapidly adding 
an aqueous solution of organic phosphate. A variety of organic phosphates 
(porphyrin, phytic acid, phosphoamino acid and surfactants) was used to 
functionalize the calcium phosphate surface. The conditions were optimized 
to prepare stable monodisperse colloids.  
Organic phosphate showed a high chemical affinity to bind to the calcium 
phosphate surface which was confirmed by the zeta potential values (-20 
mV…-35 mV). The particle size, morphology, and porosity were determined 
by the surface-adsorbed organic phosphates. For example, 
(a) p-TPPP-functionalized particles – aggregation of primary calcium 
phosphate particles (ca. 20-30 nm) into ca. 250 nm solid spherical particles. 
(b) Phytic acid-functionalized particles – solid spherical particles. 
(c) TyrP-functionalized particles – aggregation of primary calcium 
phosphate particles (ca. 20-30 nm) into ca. 250 nm hollow spherical 
particles 
(d) Alkyl phosphate-functionalized particles – needle- or flower-like 
microparticles. 
The number of phosphate groups present in organic phosphates and their 
concentration played a critical role in determining the nature of particle 
precipitation. For example, the p-TPPP molecule has four phosphate groups. 
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It functionalized the calcium phosphate surface and stabilized the particles in 
solution only when the p-TPPP to calcium concentration ratio was 1:100. If 
an excess amount of p-TPPP was used (p-TPPP:Ca2+=1:30), only the 
calcium salt of p-TPPP was obtained.  
p-TPPP-functionalized calcium phosphate nanoparticles were prepared and 
used in cell culture studies to check its viability. In collaboration with the 
Chair of Molecular Neurochemistry at the University of Bochum, the cell 
culture experiments were carried out. The p-TPPP-functionalized calcium 
particles were taken up by the NIH 3T3 fibroblast cell and no adverse effect 
was observed. This showed a good prospect that the nanoparticles can be 
used as fluorescing agents without any adverse effects in the cells.  
A new and simple method to prepare calcium phytate nanoparticles was 
described where calcium phosphate nanoparticles were used as nuclei. This 
method works only in a narrow concentration range of phytic acid. The size 
of the calcium phytate nanoparticles can be adjusted by varying the calcium 
to phytate ratio. As the colloids of calcium phytate are stable and 
biocompatible, they may be used in biomedical studies (e.g. liver and spleen 
scintigraphy) without any other stabilizing agents. 
The one-step synthesis of hollow particles was described in our study which 
is easy, simple and more convenient. The hollow spherical particles are 
formed by the direct self-assembly of the primary calcium phosphate 
nanoparticles in the presence of an excess amount of O-phospho-L-tyrosine. 
It was found from SEM measurements that the hollow morphology was not 
stable under mechanical agitation and thermal conditions. The simple 
procedure for the preparation of hollow calcium phosphate nanoparticles 
makes it advantageous over template-assisted method. These hollow 
particles may be used as drug delivery vehicles. 
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The alkyl phosphate-functionalized calcium phosphate colloids showed less 
stability. SEM measurements showed aggregated microparticles. The 
content of the alkyl phosphate in the precipitated particles was (about 10-30 
wt%) estimated by elemental analysis. This indicated that the alkyl 
phosphates on the surface of hydroxyapatite underwent an ion exchange 
reaction with inorganic phosphate ions. As a result, the surface of the 
hydroxyapatite particles covered with the hydrophobic calcium salt of alkyl 
phosphate was found as precipitate. 
 
 
 128
6. Reference 
 
[1] S. Mann, Biomineralization, Oxford University Press, Oxford, 2001. 
[2] S. V. Dorozhkin, M. Epple, Angew. Chem. Int. Ed. 2002, 41, 3130. 
[3] M. Vallet-Regi, Dalton Trans. 2006, 5211. 
[4] M. Epple, E. Baeuerlein, in Handbook of Biomineralisation, Vol. 3, Wiley-VCH, 
Weinheim, 2007. 
[5] C. Rey, C. Combes, C. Drouet, H. Sfihi, A. Barroug, Mater. Sci. Eng. C 2007, 27, 
198. 
[6] H. Lowenstam, S. Weiner, On Biomineralization, Oxford University Press, New 
York, 1989. 
[7] M. Epple, E. Baeuerlein, Biomineralisation: Medical and Clinical Aspects, 
Wiley-VCH, Weinheim, 2007. 
[8] V. Sokolova, M. Epple, Angew. Chem. Int. Ed. 2008, 47, 1382. 
[9] A. Doat, M. Fanjul, F. Pelle, E. Hollande, A. Lebugle, Biomaterials 2003, 24, 
3365. 
[10] A. Doat, F. Pelle, N. Gardant, A. Lebugle, J. Solid State Chem. 2004, 177, 1179. 
[11] W. Wang, D. Shi, J. Lian, Y. Guo, G. Liu, L. Wang, R. C. Ewing, Appl. Phys. 
Lett. 2006, 89, 183106. 
[12] J. Y. Chane-Ching, A. Lebugle, I. Rousselot, A. Pourpoint, F. Pellé, J. Mater. 
Chem. 2007, 17, 2904. 
[13] S. P. Mondejar, A. Kovtun, M. Epple, J. Mater. Chem. 2007, 17, 4153. 
[14] B. Palazzo, M. Iafisco, M. Laforgia, N. Margiotta, G. Natile, C. L. Bianchi, D. 
Walsh, S. Mann, N. Roveri, Adv. Funct. Mater. 2007, 17, 2180. 
[15] E. Boanini, M. Gazzano, K. Rubini, A. Bigi, Adv. Mater. 2007, 19, 2499. 
[16] A. Maitra, Expert Rev. Mol. Diagn. 2005, 5, 893. 
[17] Y. Kakizawa, S. Furukawa, A. Ishii, K. Kataoka, J. Controlled Release 2006, 111, 
368. 
[18] V. V. Sokolova, I. Radtke, R. Heumann, M. Epple, Biomaterials 2006, 27, 3147. 
[19] D. Olton, J. Li, M. E. Wilson, T. Rogers, J. Close, L. Huang, N. P. Kumta, C. 
Sfeir, Biomaterials 2007, 28, 1267. 
[20] V. Sokolova, A. Kovtun, O. Prymak, W. Meyer-Zaika, E. A. Kubareva, E. A. 
Romanova, T. S. Oretskaya, R. Heumann, M. Epple, J. Mater. Chem. 2007, 17, 
721. 
[21] V. Sokolova, A. Kovtun, R. Heumann, M. Epple, J. Biol. Inorg. Chem. 2007, 12, 
174. 
[22] V. Sokolova, O. Prymak, W. Meyer-Zaika, H. Cölfen, H. Rehage, A. Shukla, M. 
Epple, Mat.-wiss. u. Werkstofftech. 2006, 37, 441. 
[23] S. Mann, J. P. Hannington, R. J. P. Williams, Nature 1986, 324, 565. 
[24] J. H. Collier, P. B. Messersmith, Annu. Rev. Mat. Res. 2001, 31, 237. 
[25] L. N. Y. Wu, B. R. Genge, R. E. Wuthier, J. Biol. Chem. 2008, 283, 3827. 
[26] G. A. Ozin, N. Varaksa, N. Coombs, J. E. Davies, D. D. Perovic, M. Ziliox, J. 
Mater. Chem. 1997, 7, 1601. 
[27] S. Mann, J. Webb, J. P. Williams, Biomineralisation - Chemical and Biochemical 
Perspectives, VCH Verlagsgesellschaft mbH, Weinheim, 1989. 
 129
[28] S. Weiner, P. M. Dove, Rev. Mineral. Geochem. 2003, 54, 1. 
[29] F. C. Meldrum, Int. Mater. Rev. 2003, 48, 187. 
[30] J. B. Thompson, G. T. Paloczi, J. H. Kindt, M. Michenfelder, B. L. Smith, G. 
Stucky, D. E. Daniel E. Morse, P. K. Hansma, Biophys. J. 2000, 79, 3307. 
[31] R. Z. Wang, L. Addadi, S. Weiner, Philos. Trans. Roy. Soc. B 1997, 352, 469. 
[32] S. H. Yu, H. Cölfen, M. Antonietti, J. Phys. Chem. B 2003, 107, 7396. 
[33] G. Falini, S. Albeck, S. Weiner, L. Addadi, Science 1996, 271, 67. 
[34] D. B. DeOliveira, R. A. Laursen, J. Am. Chem. Soc. 1997, 119, 10627. 
[35] M. Neumann, M. Epple, Eur. J. Inorg. Chem. 2007, 1953. 
[36] Y. Kojima, A. Kawanobe, T. Yasue, Y. Arai, J. Ceram. Soc. Jpn. Int. Edn. 1994, 
102, 1131. 
[37] J. Aizenberg, G. Lambert, S. Weiner, L. Addadi, J. Am. Chem. Soc. 2002, 124, 
32. 
[38] H. Setoguchi, M. Okazaaki, S. Suga, in Origin, evolution, and modern aspects of 
biomineralization in plants and animals (Ed.: R. E. Crick), Plenum Press, New 
York, 1989, pp. 409. 
[39] M. G. Taylor, K. Simkiss, G. N. Greaves, M. Okazaki, S. Mann, Proc. R. Soc. 
Lond. B 1993, 252, 75. 
[40] J. Aizenberg, G. Lambert, L. Addadi, S. Weiner, Adv. Mater. 1996, 8, 222. 
[41] S. Weiner, W. Traub, FEBS Lett. 1986, 206, 262. 
[42] R. Z. Legeros, Calcium phosphates in oral biology and medicine, Karger, Basel, 
1991. 
[43] W. Suchanek, M. Yoshimura, J. Mater. Res. 1998, 13, 94. 
[44] L. L. Hench, J. Am. Ceram. Soc. 1998, 81, 1705. 
[45] E. D. Eanes, I. H. Gillessen, A. S. Posner, Nature 1965, 208, 365. 
[46] W. E. Brown, J. P. Smith, J. R. Lehr, A. W. Frazier, Nature 1962, 196, 1050  
[47] O. Suzuki, S. Kamakura, T. Katagiri, J. Biomed Mater. Res. Appl Biomater. 2006, 
201. 
[48] Y. A. Vinnikov, M. Z. Aronove, T. A. Kharkeevich, T. P. Tsirulis, E. A. Lavrova, 
Y. V. Natochin, Z. Mikrosk. Anat. Forsch. 1981, 95, 127. 
[49] F. Bosselmann, M. Epple, Met. Ions Life Sci. 2008, 4, 207. 
[50] D. Chapman, J. Mar. Biol. Assoc. UK, 1985, 65, 617. 
[51] D. B. Spangenberg, C. W. Beck, Trans. Am. Microsc. Soc. 1968, 87, 329. 
[52] D. Pollmanns, M. Hündgen, Zool. Jb. Anat. 1981, 105, 508. 
[53] S. Ueno, C. Imai, A. Mitsutani, J. Plankton Res. 1995, 17, 1381. 
[54] S. Ueno, C. Imai, A. Mitsutani, Proc. 6th Int. Conf. Coelenterate Biology 1997, 
491. 
[55] H. Tiemann, I. Sötje, A. Becker, G. Jarms, M. Epple, Zool. Anz. 2006, 245, 13. 
[56] H. Tiemann, I. Sötje, G. Jarms, C. Paulmann, M. Epple, B. Hasse, J. Chem. Soc. 
Dalton Trans. 2002, 1266. 
[57] A. Becker, I. Sötje, C. Paulmann, F. Beckmann, T. Donath, R. Boese, O. Prymak, 
H. Tiemann, M. Epple, Dalton Trans. 2005, 1545. 
[58] F. Boßelmann, M. Epple, I. Sötje, H. Tiemann, in Biomineralisation: The Biology 
of Biominerals (Ed.: E. Baeuerlein), Wiley-VCH, 2007. 
[59] V. R. Franceschi, H. T. Horner, Bot. Rev. 1980, 46, 361. 
 130
[60] H. J. Arnott, in Biological Mineralization and Demineralization, Three systems of 
biomineralization in plants with comments on the associated organic matrix ed. 
(Ed.: G. H. Nancollas), Springer Verlag, Berlin, 1982. 
[61] H. J. Arnott, P. G. E. Pautard, in Biological Calcification, Calcification in plants 
ed. (Ed.: H. Schraer), Appleton-Century-Crofts, New York, 1970. 
[62] A. Frey-Wyssling, Am. J. Bot. 1981, 68, 130. 
[63] S. R. Khan, R. L. Hackett, J. Urol. 1993, 150, 239. 
[64] W. H. Boyce, F. K. Garvey, J. Urol. 1956, 76, 213. 
[65] M. Khullar, S. K. Sharma, S. K. Singh, P. Bajwa, F. A. Sheikh, M. Sharma, Urol. 
Res. 2004, 32, 190. 
[66] N. Ciftcioglu, M. Bjorklund, K. Kuorikoski, K. Bergstrom, E. O. Kajander, 
Kidney Int. 1999, 56, 1893. 
[67] E. O. Kajander, M. Bjorklund, N. Ciftcioglu, Proc. SPIE.-Int. Soc. Opt. Eng. 
1998, 3441, 86. 
[68] N. Ciftcioglu, M. Bjorklund, E. O. Kajander, Proc. SPIE.-Int. Soc. Opt. Eng. 
1998, 3441, 105. 
[69] E. G. Cuerpo, E. O. Kajander, N. Ciftcioglu, F. L. Castellano, C. Correa, J. 
Gonzalez, F. Mampaso, F. Liano, E. G. de Gabiola, A. E. Barrilero, Arch. Esp. 
Urol. 2000, 53, 291. 
[70] K. K. Akerman, J. T. Kuikka, N. Ciftcioglu, J. Parkkinen, K. A. Bergstrom, I. 
Kuronen, E. O. Kajander, Proc. SPIE.-Int. Soc. Opt. Eng. 1997, 3111, 436. 
[71] F. A. Shiekh, M. Khullar, S. K. Singh, Urol. Res. 2006, 34, 53. 
[72] C. Kwak, H. K. Kim, E. C. Kim, M. S. Choi, H. H. Kim, Eur. Urol. 2003, 44, 
475. 
[73] R. Kumar, M. Mukherjee, M. Bhandari, A. Kumar, H. Sidhu, R. D. Mittal, Eur. 
Urol. 2002, 41, 318. 
[74] K. Cromack, P. Sollins, R. L. Todd, R. Fogel, A. W. Todd, W. M. Fender, M. E. 
Crosley, D. A. Crosley, Ecol. Bull. Stockholm 1977, 25, 246. 
[75] G. M. Gadd, Adv. Microb. Physiol. 1999, 41, 47. 
[76] O. Braissant, E. P. Verrecchia, M. Aragno, Naturwissenschaften 2002, 89, 366. 
[77] G. Cailleau, O. Braissant, E. P. Verrecchia, Naturwissenschaften 2004, 91, 191. 
[78] H. A. Lowenstam, D. McConnell, 1968, 162, 1496. 
[79] R. Cattaneo-Vietti, S. Angellini, L. Gaggero, G. Lucchetti, J. Moll. Stud. 1995, 
61, 331. 
[80] S. Mann, Nature 1988, 132, 119. 
[81] H. D. Jiang, X. Y. Liu, G. Zhang, Y. Li, J. Biol. Chem. 2005, 280, 42061. 
[82] H. Cölfen, S. Mann, Angew. Chem., Int. Ed. 2003, 42, 2350. 
[83] J. Rieger, E. Hädicke, I. U. Rau, D. Boeckh, Tenside Surfactants Deterg. 1997, 
34, 430. 
[84] O. Söhnel, J. W. Mullin, J. Cryst. Growth 1982, 60, 239. 
[85] W. Ostwald, Z. Phys. Chem. 1879, 22, 289. 
[86] C. A. Orme, J. L. Giocondi, in Model Syntems for Formation and Dissolution of 
Calcium Phosphate Minerals. In: Handbook of Biomineralization: Biomimetic 
and Bioinspired Chemistry (Eds.: E. Baeuerlein, P. Behrens), Wiley-VCH, 
Weinheim, 2007. 
[87] S. Takagi, H. Liao, L. C. Chow, Caries Res. 2000, 34, 281. 
 131
[88] F. Grases, M. Ramis, A. Costa-Bauza, Urol. Res. 2000, 28, 136. 
[89] Y. Kakizawa, K. Miyata, S. Furukawa, K. Kataoka, Adv. Mater. 2004, 16, 699. 
[90] Y. Kakizawa, K. Kataoka, Langmuir 2002, 18, 4539. 
[91] M.-Y. Ma, Y.-J. Zhu, L. Li, S.-W. Cao, J. Mater. Chem. 2008, 18, 2722. 
[92] Z. Zhong, Y. Yin, B. Gates, Y. Xia, Adv. Mater. 2000, 12, 206. 
[93] S. W. Kim, M. Kim, W. Y. Lee, T. Hyeon, J. Am. Chem. Soc. 2002, 124, 7642. 
[94] W. Tjandra, P. Ravi, J. Yao, K. C. Tam, Nanotechnology 2006, 17, 5988. 
[95] D. G. Shchukin, G. B. Sukhorukov, H. Möhwald, Angew. Chem. Int. Ed. 2003, 
115, 4609. 
[96] F. Caruso, Chem. Eur. J. 2000, 6, 413. 
[97] F. Caruso, Adv. Mater. 2001, 13, 11. 
[98] F. Caruso, R. A. Caruso, H. Möhwald, Science 1998, 282, 1111. 
[99] F. Caruso, R. A. Caruso, H. Möhwald, Chem. Mater. 1999, 11, 3309. 
[100] Q. Wang, W. Huang, D. Wang, J. Wuhan University of Technology-Mater. Sci. 
Ed. 2007, 22, 174. 
[101] Q. Wang, W. Huang, D. Wang, B. W. Darvell, D. E. Day, M. N. Rahaman, J. 
Mater. Sci: Mater. Med. 2006, 17, 641. 
[102] J. Gao, B. Zhang, X. Zhang, B. Xu, Angew. Chem. Int. Ed. 2006, 45, 1220. 
[103] H. P. Liang, H. M. Zhang, J. S. Hu, Y. G. Guo, L. J. Wan, C. L. Bai, Angew. 
Chem. Int. Ed. 2004, 43, 1540. 
[104] P. A. Wingert, H. Mizukami, A. E. Ostafin, Nanotechnology 2007, 18, 295707. 
[105] D. Walsh, L. Arcelli, V. Swinerd, J. Fletcher, S. Mann, Chem. Mater. 2007, 19, 
503. 
[106] H. T. Schmidt, B. L. Gray, P. A. Wingert, A. E. Ostafin, Chem. Mater. 2004 16, 
4942. 
[107] C. E. Fowler, M. Li, S. Mann, H. C. Margolis, J. Mater. Chem. 2005, 15, 3317. 
[108] Q. Shen, H. Wei, L. Wang, Y. Zhou, Y. Zhao, Z. Zhang, D. Wang, G. Xu, D. Xu, 
J. Phys. Chem. B 2005, 109, 18342. 
[109] L. Qi, J. Li, J. Ma, Adv. Mater. 2002, 14, 300. 
[110] D. Walsh, B. Lebeau, S. Mann, Adv. Mater. 1999, 11, 324. 
[111] C. I. Zoldesi, A. Imhof, Adv. Mater. 2005, 17, 924. 
[112] H. T. Schmidt, A. E. Ostafin, Adv. Mater. 2002, 14, 532. 
[113] Y. Cai, H. Pan, X. Xu, Q. Hu, L. Li, R. Tang, Chem. Mater. 2007, 19, 3081. 
[114] Q. Peng, Y. Dong, Y. Li, Angew. Chem. Int. Ed. 2003, 42, 3027. 
[115] J. Yu, H. Guo, S. A. Davis, S. Mann, Adv. Funct. Mater. 2006, 16, 2035. 
[116] B. Liu, H. C. Zeng, J. Am. Chem. Soc. 2004, 126, 8124. 
[117] H. G. Yang, H. C. Zeng, Angew. Chem. Int. Ed. 2004, 43, 5930  
[118] W. Ostwald, Z. Phys. Chem. 1897, 22, 289. 
[119] W. Ostwald, Z. phys. Chem. 1900, 34, 495. 
[120] A. D. Smigelskas, E. O. Kirkendall, Trans. AIME 1947, 171, 130. 
[121] E. O. Kirkendall, L. Thomassen, C. Upthegrove, Trans. AIME 1939, 133, 186. 
[122] E. O. Kirkendall, Trans. AIME 1942, 147, 104. 
[123] C. P. Collier, T. Vossmeyer, J. R. Heath, Annu. Rev. Phys. Chem. 1998, 49, 371. 
[124] C. Pacholski, A. Kornowski, H. Weller, Angew. Chem. Int. Ed. 2002, 41, 1188. 
[125] H. C. Zeng, J. Mater. Chem. 2006, 16, 649. 
 132
[126] Y. Yin, R. M. Rioux, C. K. Erdonmez, S. Hughes, G. A. Somorjai, A. P. 
Alivisatos, Science 2004, 304, 711. 
[127] Y. Yin, C. Erdonmez, S. Aloni, A. P. Alivisatos, J. Am. Chem. Soc. 2006, 128, 
12671. 
[128] Y. Yin, C. K. Erdonmez, A. Cobot, S. Hughes, A. P. Alivisatos, Adv. Funct. 
Mater. 2006, 16, 1389. 
[129] D. F. Evans, H. Wennerström, The Colloidal Domain, Wiley-VCH, New York, 
1999. 
[130] M. Subirade, A. Lebugle, Ann. Chim. Fr. 1991, 16, 41. 
[131] M. Subirade, A. Lebugle, Ann. Chim. Fr. 1993, 18, 183. 
[132] A. Lebugle, M. Subirade, V. Delpech, Hydroxyapatite and Related Materials, 
CRC, London, 1994. 
[133] F. Hoppe-Seyler, Z. Physiol. Chem. 1877-1878, 1, 121. 
[134] J. L. Soret, Compt. Rend. 1883, 97, 1267. 
[135] C. J. Weiss, J. Mol. Spectrosc. 1972, 44, 37. 
[136] E. D. Sternberg, D. Dolphin, C. Brückner, Tetrahedron 1998, 54, 4151. 
[137] K. M. Smith, D. A. Goff, R. J. Abraham, J. Org. Magn. Reson. 1984, 22, 779. 
[138] G. W. Kenner, S. W. McCombie, K. M. Smith, J. Chem. Soc. Perkin Trans 1 
1973, 21, 2517. 
[139] M. O. Senge, K. M. Smith, Photchem. Photobiol. 1991, 54, 841. 
[140] K. M. Smith, J. F. Unsworth, Tetrahedron 1975, 31, 367. 
[141] R. J. Abraham, C. J. Medforth, K. M. Smith, D. A. Goff, D. J. Simpson, J. 
Am.Chem. Soc. 1987, 109, 4786. 
[142] R. J. Abraham, A. E. Rowan, K. E. Mansfield, K. M. Smith, J. Chem. Soc. Perkin 
Trans. 2 1991, 4, 515. 
[143] R. J. Abrahma, G. E. Hawkes, X. H. Baith, Tetrahedron Lett. 1974, 16, 1483  
[144] C. B. Storm, Y. Teklu, J. Am. Chem. Soc. 1972, 94, 1745. 
[145] C. B. Storm, Y. Teklu, E. A. Sokoloski, Ann. N. Y. Acad. Sci. 1973, 206, 631. 
[146] R. Bonnet, Chem. Soc. Rev. 1995, 19. 
[147] D. J. Granville, B. M. McManuss, D. W. C. Hunt, Histol. Histopathol. 2001, 16, 
309. 
[148] E. D. Sternberg, D. Dolphin, C. Brückner, Tetrahedron 1998, 54, 4151. 
[149] F. Mitzel, S. FitzGerald, A. Beeby, R. Faust, Chem. Eur. J. 2003, 9, 1233. 
[150] K. Lang, J. Mosingera, D. M. Wagnerova, Coord. Chem. Rev. 2004, 248, 321. 
[151] R. F. Donnelly, P. A. McCarron, M. M. Tunney, Microbiol. Res. 2008, 163, 1. 
[152] V. Kral, J. Kralova, K. R., T. Briza, P. Martasek, Physiol. Res. 2006, 55, S3. 
[153] R. B. Boyle, D. Dolphin, Photochem. Photobiol. 1996, 64 469. 
[154] E. L. Clennan, Tetrahedron 2000, 56, 9151. 
[155] G. Jori, in: Proceedings of the Ciba Foundation Symposium on Photosensitizing 
Compounds: Their Chemistry, Biology and Clinical Use 1989, 146, Wiley, 
Chichester, 78. 
[156] K. Lang, J. Mosinger, D. M. Wagnerová, Coord. Chem. Rev. 2004, 248, 321. 
[157] F. Hoppe-Seyler, Med. Chem. Untersuchungen. 1871, Eberhard-Karls-
Universitat, Berlin. 
[158] H. Scherer, Ann. Chem. Pharm. 1841, 40, 1. 
[159] F. Meyer-Betz, Dtsch. Arch. Klin. Med. Chem. Untersuchungen. 1913, 112, 476. 
 133
[160] R. L. Lipson, E. J. Baldes, A. M. Olsen, J. Natl. Cancer Inst. 1961, 26, 1. 
[161] R. Benesch, R. E. Benesch, C. I. Yu, Proc. Natl. Acad. Sci. 1968, 59, 526. 
[162] A. Arnone, Nature 1972, 237, 146. 
[163] M. F. Perutz, Nature 1970, 228, 726. 
[164] A. Riggs, in Biochemical Regulatory Mechanisms in Eukaryotic Cells (Eds.: E. 
Kun, S. Grisolia), Wiley-Interscience, New York, 1972. 
[165] F. Grases, A. Llobera, Anal. Lett. 1996, 29, 1193. 
[166] F. Grases, A. Costa-Bauza, M. J. G., Br. J. Urol. 1994, 74, 298. 
[167] F. Grases, L. Garcia-Ferragut, A. Costa-Bauza, M. J. G., Nephron 1996, 73, 561. 
[168] F. Grases, L. Garcia-Ferragut, A. Costa-Bauza, Nephron 1998, 78, 296. 
[169] G. E. Blank, J. Pletcher, M. Sax, Acta. Cryst. 1975, B31, 2584. 
[170] L. R. Isbrandt, P. R. Oertel, J. Am. Chem. Soc. 1980, 102, 3144. 
[171] L. G. Barrientos, P. P. N. Murthy, Carbohydr. Res. 1996, 296, 39. 
[172] J. Emsley, S. Niazi, Phosphorus and Sulfur 1981, 10, 401. 
[173] C. Brigando, J. C. Mossoyan, F. Favier, D. Benlian, J. Chem. Soc. Dalton Trans. 
1995, 575. 
[174] Z. He, C. W. Honeycutt, T. Zhang, P. J. Pellechia, W. A. Caliebe, Soil Sci. Soc. 
Am. J. 2007, 71, 940. 
[175] A. Bebot-Brigaud, C. Dange, N. Fauconnier, C. Gerard, J. Inorg. Biochem. 1999, 
75, 71. 
[176] C. J. Martin, W. J. Evans, J. Inorg. Biochem. 1986, 27, 17. 
[177] V. Raboy, Phytochemistry 2003, 64, 1033. 
[178] I. Vucenik, A. M. Shamsuddin, J. Nutr. 2003, 133, 3778S. 
[179] B. F. Harland, E. R. Morris, Nutrition Res. 1995, 15, 733. 
[180] F. J. McClure, J. Dent. Res. 1963, 42, 693. 
[181] F. J. McClure, Science 1964, 144, 1337. 
[182] G. N. Jenkins, in Advandes in Oral Biology, Vol. 2 (Ed.: P. H. Staples), Academic 
Press, New York, 1966, pp. 67. 
[183] H. Nordbö, G. Rölla, J. Dent. Res. 1972, 51, 800. 
[184] A. J. Cozzon, Ann. Rev. Microbiol. 1988, 42, 97. 
[185] J. B. Stock, A. J. Ninfa, A. M. Stock, Microbiol. Rev. 1989, 450. 
[186] C. Chang, R. C. Stewart, Plant Physiol. 1998, 117, 723. 
[187] D. Barford, A. K. Das, M. P. Egloff, Annu. Rev. Biophys. Biomol. Struct. 1998, 
27, 133. 
[188] S. Mishra, A. W. Hamburger, Cancer Res 1993, 53, 557. 
[189] B. M. Sefton, T. Hunter, K. Beemon, W. Eckhart, Cell 1980, 20, 807. 
[190] S. Mishra, A. W. Hamburger, Carcinogenesis 1993, 14, 269. 
[191] Z. Zhang, J. Biol. Chem. 1995, 270, 16052. 
[192] S. Mishra, A. W. Hamburger, Cancer Lett. 1996, 102, 65. 
[193] R. Goobes, G. Goobes, W. J. Shaw, G. P. Drobny, C. T. Campbell, P. S. Stayton, 
Biochemistry 2007, 46, 4725. 
[194] E. C. Moreno, K. Varughese, D. I. Hay, Calcif. Tissue Int . 1979, 28, 7. 
[195] J. M. Gibson, V. Raghunathan, J. M. Popham, P. S. Stayton, G. P. Drobny, J. Am. 
Chem. Soc. 2005, 127, 9350. 
[196] D. I. Hay, E. C. Moreno, D. H. Schlesinger, Inorg. Persp. Biol. Med. 1979, 2, 
271. 
 134
[197] K. Makrodimitris, D. L. Masica, E. T. Kim, J. J. Gray, J. Am. Chem. Soc. 2007, 
129, 13713. 
[198] C. R. Eric, Protein Pept. Lett. 1999, 6, 295. 
[199] D. A. Pampena, K. A. Robertosn, O. Litvinova, G. Lajoie, H. A. Goldberg, G. K. 
Hunter, Biochem. J. 2004, 378, 1083. 
[200] E. Salih, S. Ashkar, H. Y. Zhou, L. Gerstenfeld, M. J. Glimcher, Connect. Tissue 
Res. 1996, 35, 207. 
[201] M. Lasa, P. L. Chang, C. W. Prince, L. A. Pinna, Biochem. Biophys. Res. 
Commun. 1997, 240, 602. 
[202] S. Ashkar, D. B. Teplow, M. J. Glimeher, R. A. Saavedra, Biochem. Biophys. Res. 
Commun. 1993, 191, 126. 
[203] P. J. Neame, W. T. Butler, Connect. Tissue Res. 1996, 35, 145. 
[204] W. G. Stetler-Stevenson, A. Veis, Biochemistry 1983, 22, 4326. 
[205] G. He, A. Ramachandran, T. Dahl, S. George, D. Schultz, D. Cookson, A. Veis, 
A. George, J. Biol. Chem. 2005, 280, 33109. 
[206] C. Tanford, The Hydrophobic Effect: Formation of Micelles and Biological 
Membranes, Wiley-Interscience, New York, 1973. 
[207] E. A. G. Aniansson, S. N. Wall, M. Almgren, H. Hoffmann, I. Kielmann, W. 
Ulbricht, R. Zana, J. Lang, C. Tondre, J. Phys. Chem. 1976, 80, 905. 
[208] E. Y. Sheu, S. H. Chen, J. Phys. Chem. 1988, 92, 4466. 
[209] N. M. van Os, J. R. Haak, L. A. M. Rupert, Physico-Chemical Properties of 
Selected Anionic, Cationic and Non-ionic Surfactants, Elsevier, Amsterdam, 
1993. 
[210] E. Gorter, F. J. Grendel, J. Exp. Med. 1925, 41, 439. 
[211] A. D. Bangham, R. W. Horne, J. Mol. Biol. 1964, 8, 660. 
[212] D. D. Lasic, Liposomes: from Physics to Applications, Elsevier, Amsterdam, 
1993. 
[213] T. Tahara, I. Satake, R. Matuura, Bull. Chem. Soc. Jpn. 1969, 42, 1201. 
[214] P. Walde, M. Wessicken, U. Rädler, N. Berclaz, K. Conde-Frieboes, P. L. Luisi, 
J. Phys. Chem. B 1997, 101, 7390. 
[215] J. Arakawa, B. A. Pethica, J. Colloid Interface Sci. 1980, 75, 441. 
[216] L. D. Schuler, P. Walde, P. L. Luisi, W. F. van Gunsteren, Eur. Biophys. J. 2001, 
30, 330. 
[217] Y. Han, S. Li, X. Wang, Y. Wang, Nanoscience 2006, 11, 102. 
[218] T. Kawakami, S. Igarashi, Analyst 1995, 120, 539. 
[219] J. W. Perich, R. B. Johns, Synthesis 1988, 142. 
[220] L. J. McBride, M. J. Caruthers, Tetrahedron Lett. 1983, 24, 245. 
[221] T. Welzel, I. Radtke, W. Meyer-Zaika, R. Heumann, M. Epple, J. Mater. Chem. 
2004, 14, 2213. 
[222] T. Kawakami, S. Igarashi, Analytical lett. 1994, 27, 2083. 
[223] Y. N. Konan, J. Chevallier, R. Gurny, E. Allemann, Photochem. Photobiol. 2003, 
77, 638. 
[224] B. Pegaz, E. Debefve, J. P. Ballini, Y. N. Konan-Kouakou, H. van den Bergh, J. 
Photochem. Photobiol. B-Biology 2006, 85, 216. 
[225] S. Sortino, A. Mazzaglia, L. M. Scolaro, F. M. Merlo, V. Valveri, M. T. Sciortino, 
Biomaterials 2006, 27, 4256. 
 135
[226] R. Greiner, U. Konietzny, K. D. Jany, J. Ernaehrungsmed. 2006, 8, 18. 
[227] A. Wise, Bull. Environm. Contam. Toxicol. 1981, 27, 630. 
[228] A. Wise, Bull. Environm Contam. Toxicol. 1982, 29, 550. 
[229] H. Higashi, S. Natsugoe, Y. Uenosono, K. Ehi, T. Arigami, Y. Nakabeppu, M. 
Nakajo, T. Aikou, Journal of Surgical Research 2004, 121, 1. 
[230] J. Campbell, J. C. Bellen, R. J. Baker, D. J. Cook, J. Nucl. Med. 1981, 22, Pages: 
157. 
[231] S. K. Imam, M. Killingsworth, World J. Nucl. Med. 2005, 4, 179. 
[232] M. A. A. Al-Janabi, J. Labelled Compounds and Radiopharmaceuticals 1989, 27, 
1137. 
[233] T. Welzel, W. Meyer-Zaika, M. Epple, Chem. Commun. 2004, 1204. 
[234] Z. He, C. W. Honeycutt, T. Zhang, P. M. Bertsch, J. Environ. Qual. 2006, 35, 
1319. 
[235] B. G. Santoni, G. E. Pluhar, T. Motta, D. L. Wheeler, Bio-medical Materials and 
engineering 2007, 17, 277. 
[236] T. Sugama, B. Lipford, J. Mater. Sci. 1997, 32, 3523. 
[237] R. X. Sun, Y. P. Lu, M. S. Li, Surface Engineering 2003, 19, 392. 
[238] Y. Musha, M. Abe, T. Umeda, K. Itatani, Phosphorus Research Bulletin 2006, 20, 
149. 
[239] H. T. Schmidt, M. Kroczynski, J. Maddox, Y. Chen, R. Josephs, A. E. Ostafin, J. 
Microencapsulation 2006, 23, 769. 
[240] A. Bigi, E. Boanini, D. Walsh, S. Mann, Angew. Chem. 2002, 114, 2267. 
[241] A. Bigi, B. Bracci, S. Panzavolta, M. Iliescu, M. Plouet-Richard, J. Werckmann, 
D. Cam, Cryst. Growth & Design 2004, 4, 141. 
[242] P. F. Alewood, R. B. Johns, R. M. Valerio, Synthesis 1983, 1, 30. 
[243] Y. Okamoto, Bull. Chem. Soc. Jpn. 1985, 58, 3393. 
 
 
 
 
 
 136
7. Appendix  
7.1. List of Abbreviations 
CDCl3 Deuterated chloroform 
D2O Deuterated water 
DDP Dodecyl phosphate 
DDOPhP p-dodecyloxyphenyl phosphate 
DDOBPhP p-dodecyloxybiphenyl-p'-phosphate 
DLS Dynamic light scattering 
DMSO Dimethylsulphoxide 
DNA Deoxyribonucleic acid 
EDX Energy dispersive X-ray analysis 
ESI-MS Electron spray ionisation mass spectrometer 
IR Infrared 
MCPBA meta-chloro perbenzoic acid 
MTT Methyl thiazole tetrazolium bromide 
NIH 3T3 National Institutes of Health - 3-day transfer, inoculum 3·105 cells 
NMR Nuclear magnetic resonance 
ODP Octadecyl phosphate 
PDI Polydispersity index 
PDT  Photodynamic therapy 
siRNA  small interfering Ribonucleic acid 
SEM Scanning electron microscopy 
TDP Tetradecyl phosphate 
p-THPP 5,10,15,20-tetrakis(4-hydroxyphenyl)porphine  
p-TPPP 5,10,15,20-tetrakis(4-phosphonooxyphenyl)porphine 
TyrP O-phospho-L-tyrosine 
UV-vis Ultraviolet-Visible 
XRD X-ray (powder) diffractometry 
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